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Abstract 
Some commonly-used Chinese medicines for the treatment of the liver 
have been examined. Rhizoma Coptidis (R.C.) and Abri Herba (A.H.) are used 
for the treatment of hepatitis, jaundice and various liver disorders in Asia. 
Studies of the hepato-protective effects of these herbs at the molecular level 
would allow us to elucidate the actions of these TCMs on the gene expression 
level in hepatocytes. 
In this study, effects of these herbs on the gene expression of rat 
hepatocytes (Clone 9) and hepatoma cells (H4IIE) were evaluated. cDNA 
array system was used to identify the gene expression pattern in two cell lines 
after incubation with the TCMs. Over 10 and 20 genes were induced by the 
aqueous extracts of R.C. and A.H., respectively. Among these genes, two 
detoxifying enzymes glutathione S-transferase Ya subunit [GST Ya], DT-
diaphorase [DTD], rcl’ and p21 genes were induced by 2.2 to 8-folcl. These 
detoxifying enzymes enhanced the efficiency of detoxification of xenobiotics in 
the liver and prevented the oxidative damage of the different reactive species. 
The expression level of these genes induced by R.C. and A.H. was confirmed 
by RT-PCR and Northern blot analysis. The results indicated that treatment 
with R.C. and A.H. was effective in inhibiting the cell growth of cancer cells. 
The LCso were 2 to 3-fold different between the two cell lines. The results 
indicated that induction of the growth-related gene, c-myc-responsive protein, 
厂c/ and cyclin-dependent kinase inhibitor, p21 may be involved in the 
regulation of cell cycle. R.C. and A.H. could play a role in the anticancer action. 
Thus, the mode of actions of TCMs at the molecular level provided biological 
insights into the hepatoprotective functions of TCMs. A new and effective 
formulation for the liver disorders could be developed from the study. 
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摘要 





在這研究中，這些保肝中藥的效能已在老鼠的肝細胞（Clone 9 )和肝癌 
細胞（H 4 I I E )中作出基因層面上的分析。利用互補脫氧核糖核酸陣列系統， 
兩種經過中藥處理之肝細胞之基因顯示情况已被確認。結果顯示分別超過十以 
及二十種基因因為經過被黃連及雞骨草的水提煉物處理而誘發出基因在顯示程 
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Abbreviation 
Abri Herba 
Antioxidant Response Element 
Carbon Tetrachloride 
Cyclin-dependent kinase 
Cytochrome P450 monooxygenase 
Dulbecco modified Eagle medium 
DT-diaphorase 
Fetal bovine serum 
Fructus Forsythiae 
Glyceraldehdye 3-phosphate dehydrogenase 
Glutathione S-transferase 
Hepatitis A virus 
Hepatitis B virus 
Hepatitis C virus 
Hepatitis D virus 
Hepatitis E virus 
Minimum essential medium 
Rhizoma Coptidis 
Reactive oxygen species 
Standard Saline Citrate 
Traditional Chinese medicines 
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1.1 Traditional Chinese Medicines (TCMs) 
The traditional Chinese medicines have been widely used as 
pharmaceutical agents for thousands of year; thus, the use of TCMs have 
been demonstrated for the treatment of certain diseases, in particular for the 
cancer treatment. TCMs exhibited less toxicity and undesired side effects. 
Abundance of both flora and medicinal plants resources also made them for 
use to the public as well as fundamental study. They become important source 
for modern research for new drugs. A survey of these plants indicated that 
over 5000 species with potential therapeutic value, of which about 500 species 
were in common usage. Medicinal plants had received much more attention 
not only due to their therapeutic benefits but also because they could provide 
novel chemical structures, which may be used a rational lead for experience of 
traditional Chinese medicine. In China, herbal medicines were usually 
prepared in a formulation with different species and preparation procedures. 
Two or more drugs were usually combined together compatibly and purposely 
in line with the specific conditions for the treatment of diseases. These 
combinations of drugs became the major form of application of Chinese drugs 
and constituted the foundation of prescription. 
Although a number of diseases have been counteracted by the 
improvement of sanitary conditions and the developments of drugs, especially 
the vaccines and antibiotics, there are still a great number of people who 
suffered from the liver disorders. 
Viral infection is the major cause of liver disorders, however different 
chemicals or substances such as, ethyl alcohol, peroxidized edible oil, toxins 
in food, hepatotoxic chemicals and pharmaceuticals, also attack the liver. 
Nevertheless, no good remedy for liver disorder has been provided in the 
-2-
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modern medicine. Due to the increasing interest in Chinese herbal medicine, 
numerous studies on medicinal plants have been reported. New formulations 
had curative effect on liver disorders. This also became the motivation of the 
investigation of herbal medicine to develop efficacious drugs for liver disorders. 
The elucidation of active constituents of those medicinal plants is important for 
substantiation of antihepatotoxic activities. 
1.2 Liver disorders in Asia Pacific regions 
Disorder of the liver is one of the most common diseases in the Asia 
Pacific regions. According to the survey of World Health Organization (WHO), 
people of Asia Pacific regions and Africa were the high-risk groups of liver 
cancer and hepatitis A, B, C and E (figure 1.1 to 1.5). As the liver disease is 
the common cause of death in these regions, and the mortality rate of the liver 
disorder was maintained at high level over decades. An alternative method for 
the treatment of the diseases was needed. The traditional Chinese medicine 
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Figure 1.3 The geographic distribution of hepatitis A virus infection 
Geographic Pattern of Hepatitis B Prevalence, 1997 
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Figure 1.4 The geographic distribution of hepatitis B infection 
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Figure 1.5 The geographic distribution of hepatitis C infection 
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1.3 Classification of liver disorders 
Liver disorders were a large variety of diseases related to the 
dysfunction of liver. These diseases were difficult to be classified clearly 
because of the obscure etiology and pathogenetic mechanisms. The prevalent 
system of classification is based on the anatomy, i.e. diseases of hepatic 
parenchyma, diseases of the hepatobiliary system and the diseases of hepatic 
vascular system (Worman, 2001). 
For the parenchymal diseases, they are related to the dysfunction of 
the hepatocytes themselves and can be further divided into mild, moderate 
and severe diseases. Suffering from the mild and the moderate diseases can 
result in cell necrosis which manifests elevated transaminase levels, decrease 
in protein synthesis and conjugation of bilirubin. For the severe hepatocellular 
dysfunction, the protein synthesis will be halted and result in prolonged clotting 
times and bleeding as well as failure to remove ammonia and drugs. These 
dysfunctions can be caused by a variety of etiologies, such as viral, drug 
induced hepatitis, cirrhosis and space-occupying lesions, i.e. hepatoma, 
mutastatic tumors (Godwin, 1995). 
For hepatobiliary disorders, these reflect the inability to make or secrete 
bile and commonly known as the cholestatic disorder. The problem may be 
due to the obstruction of the biliary tree or hepatocellular dysfunction. 
Classically, this cellular deficit occurs in patients that are hypersensitive to 
phenothiazine and the etiologies of hepatobiliary disorders are usually due to 
the extrahepatic or intrahepatic biliary obstruction as well as inflammation of 
the biliary tree (cholangitis) (Worman, 2001). 
The hepatic vascular disorders can be caused by hemorrhagic necrosis 
of centrilobular hepatocyte. This can result in increase in pressure along the 
- 7 -
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hepatic vessels and known as portal hypertension. If the case is untreated, 
there is centrilobular fibrosis and fibrous bridging of adjacent central veins will 
be formed in serious case. Cardiac Sclerosis will be eventually developed. 
1.3.1 Hepatitis 
Hepatitis means inflammation of the liver, and the most common cause 
was the infection with one of 5 viruses, called hepatitis A，B’C，D，and E. This 
type of liver disorder was commonly found in Asia or other developing 
countries with increasing inflection rate (WHO, 2000). All of these viruses 
could cause an acute disease with symptoms lasting several weeks including 
yellowing of the skin and eyes (jaundice); dark urine; extreme fatigue; nausea; 
vomiting and abdominal pain. It can take from several months to a year to feel 
fit again. Hepatitis B virus can cause chronic infection in which the patient 
never gets rid of the virus and many years later will develop cirrhosis of the 
liver or liver cancer. HBV is the most serious type of viral hepatitis and the only 
type causing chronic hepatitis for which a vaccine is available. 
1.3.1.1 Hepatitis A virus infection 
Hepatitis A is a case of liver inflammation inflected by hepatitis A virus 
(HAV). This type of hepatitis is one of the oldest diseases known to 
humankind, which is a self-limited disease that results in fulmitant hepatitis 
and death in only small proportion of patients. The transmission of hepatitis A 
virus is passed through the fecal/oral pathway and it is common in children or 
young adults especially in areas of poor sanitary condition. Most patients 
could be recovered fully in several weeks without chronic symptoms and 
carrier state. 
The hepatitis A is caused by the inflection of HAV. This virus is a non-
enveloped, positive stranded RNA virus (enterovirus, picorna group, 25-28nm) 
- 8 -
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(figure 1.6) which is found primarily in feces and causes a transient viremia. 
This virus interferes with the liver functions while replicating in the hepatocytes. 
The individual's immune system was then activated to produce a specific 
reaction to combat and possibly eradicate the infectious agents. As a 
consequence of pathological damages, the liver became inflamed. 
As hepatitis A is viral diseases, so that antibiotics became meaningless 
in the treatment of the infection. Nevertheless, antiviral agents as well as 
corticosteroids have no effects in the management of the acute diseases. The 
therapy of the hepatitis A only can be supportive and aimed at maintaining 
comfort and adequate nutritional balance (Pattern, 2000). 
1.3.1.2 Hepatitis B virus infection 
Hepatitis B was one of the major diseases of mankind and was a 
serious global public health problem. Of the 2 billion people who have been 
infected with the hepatitis B virus (HBV), more than 350 million have chronic 
(life-long) infections. These chronically infected persons are at high risk of 
death from cirrhosis of the liver and have a strong epidermiological association 
with hepatocellular carcinoma. Hepatitis B virus (HBV) Infection also induces 
inflammation of liver. This virus can cause acute and chronic diseases with 
symptoms of jaundice, dark urine fatigue, nausea, vomiting and abdominal 
pain (Worman, 2001). 
In Asia, there were hundreds of millions of individuals that may be 
infected by HBV. This DNA virus; a DANE particle (42nm) composed of an 
inner core and lipoprotein envelop, was transmitted horizontally by blood and 
blood products and sexual transmission. It was also transmitted vertically from 
mother to infant in the perinatal period. The genome of HBV consisted of four 
genes: pol, nev, pre-core and X which are encoded the viral DNA-polymerase， 
-9-
Introduction 
Figure 1.6 Electron Microscopy (EM) picture of HAV 
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envelop protein, pre-core protein and protein X，respectively. The function of 
the protein X was still unclear but it was believed that it involved in the 
activation of host cell genes and the development of cancer (Worman, 2001). 
In much of the developing world (sub-Saharan, Africa, most of Asia and 
the Pacific), most people were infected in the childhood and 25-35% of people 
became chronically infected and became high risk of developing severe 
diseases including chronic active hepatitis, cirrhosis and primary 
hepatocellular carcinoma (WHO, 2001) 
1.3.1.3 Hepatitis C virus infection 
Hepatitis C is viral infection of the liver which has been referred to as 
parenterally transmitted "non A, non B hepatitis" until the identification of 
causative agent in 1989. Hepatitis C virus (HCV) is a major cause of acute 
hepatitis and chronic liver diseases. There were estimated 170 millions 
persons chronically infected with HCV globally (WHO, 2000). Unscreened 
blood transfusions, reuse of needles and syringes were the major routes of 
spreading of HCV. This type of enveloped RNA virus appeared to have narrow 
host range; human as well as the chimpanzees are the only known species 
susceptible to infection. 
No vaccine was available currently for the prevention of hepatitis C and 
treatment for chronic hepatitis C is too costly and not suitable for most people 
in developing counties. Thus an alternative economic remedy of hepatitis was 
increased in attention (WHO, 2000). 
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1.3.1.4 Hepatitis D virus infection 
The hepatitis D virus (HDV) (also called delta virus) was a small circular 
RNA virus. The hepatitis D virus is replication defective and therefore cannot 
propagate in the absence of another virus. In humans, hepatitis D virus 
infection only occurs in the presence of hepatitis B infection. This type of virus 
infection is transmitted by cross-contamination of blood and blood products. 
Co-infection of HBV and HDV may occur and patient can acquire hepatitis D 
virus infection at the same time as he/she is infected with the hepatitis B virus. 
Hepatitis D distribution parallels that of HBV infection and in some HBV-
prevalent countries such as China, HDV infection is disproportionately low 
(Worman, 2001). 
1.3.1.5 Hepatitis E virus infection 
Infection of hepatitis E virus (HEV) could cause the self-limited acute 
viral hepatitis in adults aged from 15 to 40. This non-enveloped, spherical, 
positive-stranded RNA virus had a restricted distribution. The epidemic of 
hepatitis E has been found in much of Central and South-East Asia, North and 
West Africa, and in Mexico, confined to geographic areas where faecal 
contamination of drinking water was common. Hepatitis E is a mild to 
moderate disease in severity (mortality rate of 0.4-4.0%) except in pregnancy, 
where the mortality rate is progressively higher in each succeeding trimester 
and may reach 20% (WHO, 2001). At present, no commercially available 
vaccines existed for the prevention of hepatitis E. As no specific therapy is 
capable of altering the course of acute hepatitis E infection, prevention is the 
most effective approach against the disease. 
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1.3.2 Cancer of the liver 
Liver cancer is not a specific term of the diagnosis. Liver cancer could 
be divided into two different categories, metastatic liver cancer and 
hepatocellular carcinoma. Most liver cancer patients in the western world are 
cancer that originates in other organs and spread to liver via the bloodstream. 
This type of cancers called metastatic liver cancer. Patients who suffered from 
chronic liver diseases such as hepatitis B, C or cirrhosis, primary cancers 
could originate in the liver and mostly being the hepatocellular carcinomas. 
This primary cancer was very common in Africa and Asia. Another primary 
type of liver cancer was cholangiocarcinoma, which was originated from the 
bile ducts and had a less proportion of lethal case when compared with 
metastatic liver cancer and hepatocellular carcinoma (Worman, 2001; WHO, 
2000). 
1.3.2.1 Hepatocellular carcinoma 
Hepatocellular carcinoma is the world leading cause of cancer death. 
This primary cancer is especially prevalent in Asia and Africa. About 80% of 
patients with hepatocellular carcinoma had cirrhosis and infection of hepatitis 
B，C virus would increase the risk of developing this type of cancer. On the 
other hands, aflatoxins, which are toxic chemicals produced by a mold, have 
also been implicated as a major risk factor for causing hepatocaellular 
carcinoma. This group of toxic chemicals was common in Southeast Asia and 
Africa and often in contaminated food. Aflatoxin could lead to cirrhosis, which 
•s a severe and irreversible scarring of the liver that leads to repeated cycles of 





Another primary liver cancer is cholangiocarcinoma that arises from bile 
duct epithelium and is usually caused by infection of liver flukes and thorotrast. 
Patients with sclerosing cholangitis were also at increased risk for the 
development of cholangiocarcinoma. This type of cancer had only 10% of 
occurrence frequency when compared with hepatocellular carcinoma 
(Worman, 2001). 
1.3.2.3 Metastatic liver cancer 
Metastatic cancers are tumors that spread from the organ or origin. 
Because of blood supply, the liver was a common site for some cancers to 
spread. Some of the most common cancers that spread to the liver were those 
originating in the colon, pancreas, lung, and breast. There were several types 
of treatment offered currently. The most frequently used treatment was 
chemotherapy and many experimental therapies for metastatic cancers were 
also under investigation in clinical trials at numerous medical school and 
hospitals. 
1 _4 Conventional treatment of liver disorders 
Treatment and vaccination of hepatitis and hepatocellular carcinoma 
became the most important strategies to control the spreading of these 
common liver disorders. However, there are only several subtypes of hepatitis 
that have the vaccination and effective treatment. For instance, attenuated or 
inactivated HAV could be used as the vaccination of hepatitis A and 




No vaccination is currently available for the hepatitis C, D and E and the 
alpha interferon is the most commonly used drug for the treatment of B, C and 
D subtypes. The effectiveness of the alpha interferon varied from type to type 
and numerous adverse side effects such as depression and fever became the 
major problems of treatment. The cost of the hepatitis treatment made many 
developing countries difficult to support the treatment of the patients. Thus, 
development of an alternative cost-effective treatment or prevention method 
was initiated in different countries. 
For the development of treatment strategies of liver cancer, different 
problems arose. Because of the correlation of the chronic liver diseases and 
the formation of hepatocarcinoma, it could not be prevented effectively. On the 
other hand, the liver cancer is almost the lethal disease. Patients with 
hepatocellular carcinoma usually have already been damaged in the liver. This 
made the treatment of cancer difficult. Cancer cells usually were killed in two 
different ways when using chemotherapy. First of all, cancer cells were killed 
by chemotherapy by directing anticancer drugs to the blood vessels that feed 
the liver and tumor. Secondly, A tiny particles were injected to block the 
feeding vessels that can cut off the supply of blood flow to the tumor 
(Szczepanski, 2000). Chemotherapy is usually given through a vein. This type 
of treatment may not always work well for primary liver cancer. 
Radiotherapy was also used for the cancer treatment, however the 
high-dose energy of radiation will kill the cancer cells and liver cells as well. 
Thus radiation was seldom used. 
The only curative strategy of primary liver cancer was the complete 
removal of tumor or to have the liver transplant surgically. This operation was 
only possible when the tumor size was small and remained a sufficient portion 
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of functional liver. However if the surgery was not possible, the liver cancer 
became difficult to cure. 
As the tight relationship between the liver cancer and the hepatitis or 
other chronic liver disease becomes known, effective treatment and preventive 
measures should be developed. 
1-5 Roles of Traditional Chinese medicines in 
hepatoprotective functions 
Different herbal medicines were used as effective measures for the 
treatment of liver disorders. Different research groups indicated that many 
TCMs were effective in inhibiting the cell growth of liver cancer cells or 
processes antihepatotoxic activities. These liver-protective plants, such as 
Alisma orientale, Atractylodes japonica, have showed a significant 
hepatoprotective function in the intoxicification of CCI4. However, the exact 
effects of the TCMs on the hepatoprotective functions at the molecular level 
were still unclear. The uncertainty of the hepatoprotective functions of TCMs 
hindered the development of TCMs as the conventional agents for treatment 
of liver disorders. 
The effects of TCMs at the molecular level should be investigated in 
order to clarify the effects and mechanisms of the TCMs and the active 
constituents can be identified for the further development of new drugs of liver 
disorders. 
Effects of TCMs on the transcriptional and the translational level of 
cancer cells were studied. Different constituents of TCMs may have effects on 
the expression level of the mRNA of different genes. By analyzing the change 
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in expression level of these genes, it could provide an insight into the 
biological functions of TCMs on the liver disorders. 
1.5.1 Abri Herba {Abrus Cantoniensis Hance) 
In Hong Kong and Asia Pacific region, TCMs were commonly used as 
the alternative methods for treatment of various diseases. People usually 
realized that the effects of TCMs were more effective to certain diseases but 
the actions of this treatment was much slower than conventional medicine. 
Usage of prescriptions in TCMs usually complicates the pharmaceutical 
actions of TCMs. These complicated actions of TCMs increased the difficulty 
for the analysis of actions of TCMs on the molecular level. Thus, individual 
herbal medicine with hepatoprotective functions was studied. 
Abri Herba (A.H.) (figure 1.7) was Abrus Cantoniensis Hance (figure 
1.8). This herbal medicine was not recorded in any traditional herbs. However, 
it was the commonly known herbal medicine that can treat various liver 
diseases in China. In the traditional Chinese medicine, A.H. had a pungent 
flavor and warm property. This herb was effective in the treatment of chronic 
hepatitis, cirrhosis and jaundice. A.H. could reduce the hemolysis of red blood 
cells at high concentration. A.H. consisted of different chemicals including 
abrine (figure 1.9) and choline, other compounds such as sophoradiol, 
cantoniensistriol. hypaphorine and glycyrrhizin were mainly found in the root of 
the plant. These compounds might play role in hepatoprotective functions and 
the exact effects of A.H. were analyzed at molecular level in this project. 
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Figure 1.7 The appearance of the dried plant of A.H. 
Figure 1.8 Abrus Cantoniensis Hance 
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Figure 1.9 The chemical structure of L-Abrine 
1.5.2 Rhizoma Coptidis (Coptis chinensis Franch) 
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Huanglian, Rhizoma Coptidis (R.C.) (figure 1.10), was the dry rhizome 
of Coptis chinensis Franch (figure 1.11). R.C. was bitter in taste, cold in nature 
and attributive to heart, liver, and stomach, Different herbs of traditional 
Chinese medicines indicated that R.C. was an antibacterial agent. It was 
claimed R.C. could inhibit the carbohydrate metabolism and protein synthesis 
of bacteria (Chinese medicine of plant origins). This herb also has antiviral and 
antiprotozoal effect, It can improve the immune system and phagocytic 
process. Anti-inflammation and antineoplastic effect of R.C. was also identified 
(Chang et al, 1987). This herb was effective in the treatment of hepatitis, 
jaundice, inhibiting the cells growth of liver cancer, and had choleretic effect by 
increasing the production of bile (Chang et al., 1987). 
Berberine and many quaternary protoberberine type alkaloids such as 
palmtine，jatrorrhizine and coptisine was found in the extract of R.C. The 
berberine was shown to be the major active constituent related to its 
pharmaceutical actions. R.C. mainly contains berberine in 5-8%. It was 
reported that it possesses antibacterial, antiviral, antineoplastic and choleretic 
effects which is coincide the pharmaceutical actions of R.C • 
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Figure 1.10 The dried Rhizoma Coptidis in commercial 
• 
Figure 1.11 The origin of the Rhizoma Coptidis {Coptis Chinensis Franch) 
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1.5.3 Fructus Forsythiae (Forsythia suspensa (Thunb.) 
Vahl.) 
Lianqiao, Fructus Forsythiae (F.F.) (figure 1.12), was the dried fruits of 
Forsythia suspensa (Thunb.) Vahl. (figure 1.13) was collected in the fall when 
the fruits became ripe. This well-known traditional Chinese medicine is widely 
used as anti-inflammatory and antipyretic in the treatment of bacteria infection. 
This herb is listed in Chinese Pharmacopoeia and it was proved that F.F. 
could alleviate hepatic degeneration and necrosis induced by carbon 
tetrachloride. It also facilitates the recovery of the hepatocellular glycogen and 
RNA to normal level. In the clinical study of F.F, administration of this herb 
was effective in rapid lowering of serum transaminase in acute viral hepatitis. 
The exact active constituents of F.F. responsible for the 
hepatoprotective functions are unclear. This herb consists of different phenolic 
glycosides, lignans and some Ce- C2 natural alcohols. Among the lignans, it 
included of diphenyl-perhydrofurotetrahydrofurane type and 2,3-
dibenzylbutyrolactone type glucosides (figure 1.14). For the phenolic 
glycosides type compounds, forsythiaside, forsythioside C, forsythioside D, 
and forsythioside E (figure 1.15) was isolated from the fruit of F. suspense. 
Rengyol and its glucoside rengyoside A, rengyoxide, rengyolone and 
cornoside as well as salidoside (figure 1.16) were identified natural alcohol 
from F.F. In the study of these compounds, only forsythioside C and 
forsythioside D exhibited antibacterial activities (Tang et al., 2000). 
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Figure 1.12 The dried fruits of Forsythia suspensa (Thunb.) Vahl. 
Figure 1.13 Forsythia suspensa (Thunb.) Vahl. found in China 
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Figure 1.14 The diphenyl-perhydrofurotetrahydrofurane type lignans in F.F. 
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Figure 1.15 2,3-dibenzylbutyrolactone type lignans in F.F. 
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Figure 1.16 Phenolic glycosides isolated from F.F. 
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Figure 1.17 Natural alcohols isolated from Fructus Forsythiae 
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1.6 Molecular studies of hepatoprotective effects of 
TCMs 
In order to characterize the molecular actions of these herbal medicines 
in the hepatoprotective functions, these herbal medicines were analyzed at the 
molecular level. The gene expression level of hepatocytes became the focus 
of research on the hepatoprotective functions of TCMs. In the traditional 
Chinese medicines, herbal medicines were usually prepared in a unique 
procedure for the treatment of specific diseases. The aqueous extracts of A.H.， 
R_C. and F.F. were usually used for the treatment of liver disorders. Genes, 
which were related to hepatoprotective functions were identified by monitoring 
the expression level of these genes. The effects of the dosage and 
pharmacokinetic studies were examined in order to study the functions of 
genes that were induced by herbal medicines. By understanding the functions 
of the genes, the actions of these TCMs can be disclosed. The relationship 
between the active constituents of these TCMs and the gene expression were 
studied in order to identity the action mechanisms of the TCMs which were 
responsible for the hepatoprotective function. 
The effectiveness of TCMs on the inhibition of cancer cell growth was 
investigated intensively in different research sectors. The traditional Chinese 
medicines were prepared from the natural products. Problems, which were 
caused by the synthetic chemicals in the modern anticancer drugs, could be 
reduced. By investigating the genes that related to the cell growth or cancer 
development, the effectiveness of TCMs on the cancer treatment could be 
assured. 
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1.6.1 Roles of detoxification enzymes in 
hepatoprotection 
All organisms can be exposed to toxic chemicals. Many of these 
chemicals we encounter are found in the environment. Certain toxins including 
natural and synthetic chemicals are most potent carcinogenic. In addition to 
these exogenous chemicals, reactive oxygen species (ROS) such as 
superoxide that arise as a consequence of aerobic respiration, ionizing 
irradiation and inflammation can generate a wide spectrum of harmful 
carbonyl-containing compounds through interaction with membrane lipids and 
DNA. Various defense mechanisms have evolved to protect cells against 
these noxious compounds. The metabolism of foreign compounds usually 
involved two distinct stages, commonly referred to as phases I and II. Phase I 
metabolism involves an initial oxidation of the xenobiotic by cytochrome P450 
(CYP) monooxygenases. This is followed by phase II metabolism, which 
frequently involves conjugation reactions catalyzed by glutathione S-
transferases (GST), UDP-glucuronosyl transferase and sulfotransferase or 
reduction reactions catalyzed by quinone reductase and epoxide hydrolase. 
In different studies of traditional Chinese medicines, many 
hepatoprotective functions of herbal medicines were related to the conjugation 
of tripeptide glutathione by various classes of GST. GSTs [EC 2.5.1.18] have 
the detoxification functions to different carcinogens and reduce the probability 
of carcinogenesis. Alpha class of GST was effective in binding bilirubin. 
Excessive bilirubin would inhibit the functions of all classes of GST except the 
alpha class (Belinsky，et., al., 2001). This type of GST was usually expressed 
at high level in normal liver cells and reduced in expression in the process of 
hepatocarcinogenesis. Reduction of alpha class of GST implied that the 
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effectiveness of detoxification by the GST was reduced due to the inhibition of 
excessive bilirubin to other classes of GST. Different classes of GST had 
broad substrate specificity due to structural difference (figure 1.17) of the 
enzymes. This enzyme was involved in the protection of various liver disorders. 
Malfunction or reduction of GST in translational or transcriptional level will also 
impair the hepatoprotective functions of this class of enzyme. 
DT-diaphorase (DTD) [EC 1.6.99.2] was known as the anticarcinogenic 
marker enzyme. This enzyme could be elevated in expression by numerous 
xenobiotics. Induction of DTD led to the detoxification of eletrophiles and has 
been proposed to protect cells from the toxic and neoplastic effects of further 
xenobiotic assaults (Talcott et al.，1983; Belinsky et al.，1993; Ross et al., 
1993). DT-diaphorase was a homodimeric flavoprotein that catalyzes a two-
electron reduction of quinone and redox dyes. This enzyme protects cell 
against free radicals and toxic oxygen metabolites generated by the one-
electron reductions catalyzed by cytochromes P450 and other enzymes as 
well as exogenous free radicals, metals, and other electrophiles. 
Numerous studies indicated that DTD had obvious anticancer actions 
especially for the liver cancer (Hommes et al., 1979; Ip et al., 2000). 
Significant induction of DTD mRNA was recorded in hepatocytes after the 
treatment of hepatocarcinogens. These findings showed that DTD was 
effective in against chemical hepatocarcinogensis. Transient transfections with 
gene fusions and deletion mutagenesis have shown that DTD contains 
regulatory elements. There were multiple upstream elements influencing 
transcription in response to foreign chemicals and their metabolites. The 
xenobiotic response element in the upstream region of DTD gene interacts 
with aryl hydrocarbon receptor to induce transcription. The aryl hydrocarbon 
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receptor-independent ARE is also found the regulatory region of the gene and 
influence both basal and inducible expression. This regulatory element 
conferred inducibility in response to phenolic antioxidants, hydrogen peroxide, 
metabolites of planar aromatic compounds and other chemicals that undergo 
reduction to generate reactive oxygen species (Hommes, 1979). 
1.6.2 Studies of growth-related genes in cell cycle control 
The cellular growth control of individual cell was the target of studies of 
the hepatoprotective functions of TCMs. By understanding the effects of these 
herbals medicines on the cell cycle control machinery, the anticancer 
properties of TCMs can be revealed. The control of cell proliferation involved 
the maintenance of balance between the DNA replication and the cell growth. 
The cell cycle was under the control of cyclins, their dependent kinases and 
theis target genes, which functioned as key switches in the commitment to 
DNA synthesis (Zhu et al.，2001). The tight coordination of huge amounts of 
effectors or regulators was essential to keep the normal cell proliferation. 
Deregulation of any part of cell cycle machinery would lead to apoptosis or 
unregulated cell growth that may eventually lead to occurrence of 
carcinogenesis. 
The cell division is coupled to cell growth. Some c-myc target genes 
were reported to be regulator of cell growth. Some of them were involved in 
signal pathway controlling cell division (Meichle et al., 1992). c-myc was 
apparently poised at the interface of these processes . The c-myc forms a 
heterodimer with its counterpart protein Max bind to the specific DNA 
sequences CAC(A/G)TG or E-box and activate transcription. This proto-
oncogene has been well studied by different laboratories. However, the 
biochemical functions for downstream effectors of the c-myc are just beginning 





Figure 1.18 Dimeric structures of different classes of GST 
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to emerge. A putative c-myc-responsive gene, rc/ , is identified recently (Lewis 
et al., 1997). This novel growth-related gene was characterized and the exact 
functions were still under exploration. This gene has a direct relationship with 
the c-myc and the RNA or protein expression level can be stimulated by c-myc. 
Studies also indicated that elevated rc/level was found in lymphoid cells which 
overexpressed c-myc. This gene was also responsible for the stimulation of 
the growth system of regenerating liver as well as the induction of anchorage-
independent growth of cells. These data suggested that rcl played a role in 
growth control during cellular proliferation (Lewis et aI., 1997). 
Progression through the cell cycle was mediated by the activation the 
cycilin-dependent kinases (CDKs). CDKs are regulated by complex formation 
with a cyclin partner and by phosphorylation at specific residues (Gartel et 
al,1999). Two families of proteins associated with specific cyclin-CDK 
complexes and acted as CDK inhibitors. p16 family (p16/lnk, p15, p18, p19) 
which competes with cyclins D for binding to CDK4 and CDK6, thereby 
negatively regulating kinase activity (Zhu et aI., 2001) and p21 family (p21 , 
p27, p57) forms complexes with a wider range of cyclin-CDK complexes. The 
p21 protein has been shown to be a potent inhibitor of CDK2 and CDK4 
kinase activity that directly interacts with cyclin-CDK complexes and thus 
arrested the cell proliferation (Gartel et al. , 1999). In addition , p21 forms 
complexes with proliferating-cell nuclear antigen , a subunit of DNA 
polymerase 0, and prevent processive DNA synthesis. Recent studies have 
indicated that the transcriptional regulation of p21 was part of physiologically 
important proliferative, developmental, and differentiation processes (Zhu et 
al., 2001; Moustakas et ai, 1998). Results also implicated that p21 was an 
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important target in the growth regulation of normal hepatic-derived cells and 
perhaps their transformed counterpart (Kinoshia, 1985). 
Gene encoding p21 was regulated by at least three classes of signals 
that result in arrest of cell growth. The tumor suppressor protein p53, p73 and 
BRCA1 that were activated by DNA damage caused by radiation was the first 
class of protein that stimulated the transcription of p21. Extracellular growth 
factors acting in a p53-independent mechanism such as necrosis factor a, 
transforming growth factor p and factors that induce cellular differentiation also 
regulate the p21 transcription (Moustakas et al, 1998). The gene promotor of 
p21 contains at least two binding sites for the transcription factors p53 and 
specific DNA motifs responsible for the response to extracellular growth 
factors and hormones. 
Regulation of the expression level p21 becomes crucial in the cell 
growth and proliferation. Thus, effects of TCMs on the cell cycle regulator 
becomes the focus of studies on the anticancer or antiproliferative functions of 
TCMs. 
1.7 Aims of the project 
In this study, the aqueous extracts of A.H., R.C. and F.F. were prepared. 
As these herbs were believed to link to the hepatoprotective functions, the 
exact pharmaceutical actions of these herbs were unknown. The work aims at 
studying their functions at the molecular level. The machinery of cell cycle 
control and the detoxifying enzymes became the major targets of studies. By 
investigating the relationship between these targets genes and the 
hepatoprotective functions of the TCMs, the biochemical properties and 
actions of A.H.，R.C. and F.F. can be identified. 
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1.8 Application of the project 
Abri Herba, Rhizoma Coptidis and Fructus Forsythiae were easily found 
and were abundant in the Hong Kong and South China region. These 
common herbs were regarded as hepatoprotective herbs in traditional Chinese 
medicine. In the Chinese society, people usually use herbal medicine as an 
additive in diet. The enormous market of herbal medicine and abundance of 
the herbs lead to reduction of cost. The valuable pharmaceutical actions and 
economical cost lead to the attention and development of TCMs. Revealing 
the biochemical actions of the hepatoprotective functions of herbal medicines 
became the starting point to develop new economic and effective drugs for 
liver disorders from the natural environment. 
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2.1 Screening of Traditional Chinese Medicines 
In this study, three different TCMs were selected for the 
treatment of rat hepatoma H4IIE and rat normal liver Clone 9 cells. The Abri 
Herba (A.H.), Fructus Forsythiae (F.F.)�Rhizoma Coptidis (R.C.). These TCMs 
were commonly used as the treatment agents of various liver disorders in the 
traditional Chinese medicine, and they can be used alone for the treatment of 
liver diseases without aid or combination of other TCMs. From previous 
reports of traditional Chinese medicine, these TCMs were reported to possess 
antineoplastic function, however the exact pharmacological and biological 
actions of these TCMs still need further investigation. 
2.2 Preparation of TCMs 
In this study, both aqueous extracts and some of active components of 
TCMs were investigated. The methods of preparation were showed as follows: 
2.2.1 Preparation of aqueous extracts of TCMs 
The TCMs were purchased from TCM stores in Hong Kong. TCMs were 
cut into small pieces and soaked with water overnight. For each preparation of 
TCMS, 100g of TCMs were used for reflux in 2 liters of water for two hours. 
The aqueous extracts were filtered by cotton wool to remove large particles. 
The filtered TCMs extracts were centrifuged at lOOOOg for ten minutes and the 
supernatant was centrifugated at 35000g for 10 minutes using Beckman 
Avanti™ J30I Centrifuge with rotor J LA 16.25. The obtained supernatant was 
filtered with 0.45pm (GSWP04700) and 0.22Mm (HLVP04700) pore size filter 
membrane from Millipore China Ltd. The filtered supernatant was frozen in -
20 0 C and then -80 ° C, the supernatant was freeze-dried using Savant 
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ModulyoD 4K freeze-dryer. The dried TCMs were dissolved in PBS of fixed 
concentration. 
2.2.2 Preparation of active components of TCMs 
In this study, only the active components of Abri Herba and Rhizoma 
Coptidis were studied. The Abri Herba consisted different components (table 
2.1). It was reported that L-abrine (Aldrich Chemicals. Co, USA) was major 
active component that related to its functions. For the Rhizoma Coptidis (table 
2.2)，berberine (Sigma Chemicals Co, USA) was reported to be the active 
component of Rhizoma Coptidis and possessed anticancer properties. In 
preparation of L-abrine and berberine, both chemicals were dissolved in 
DMSO to the concentration of 10mM and 5mM as the stock solution and 

















Table 2.1 Chemical constituents of Abri Herba 
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R= R1= R2= R3= R4= 
Berberine -O-CH2-0- OCH3 OCH3 H 
Worenine -O-CH2-0- -O-CH2-0- CH3 
Coptisine -O-CH2-0- -O-CH2-0- H 
Palmatine OCH3 OCH3 OCH3 OCH3 H 
Jatrorrhizine OH OCH3 OCH3 OCH3 H 





Table 2.2 Chemical structure of components of Rhizoma Coptidis 
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Chemical constituents Type Compounds 

























Flavone glycoside rutin 
Table 2.3 Chemical Constituents of Fructus Forsythiae 
-39-
Materials and Methods 
2.3 In vitro assays 
Two different arrays were carried out to study the functions of different 
TCMs in liver disorder using rat normal liver cells, Clone 9 ATCC CRL-1439) 
and rat hepatoma, H4IIE (ATCC CRL-1548). 
2.3.1 Cell culture 
The rat hepatoma H4IIE and rat normal liver Clone 9 cells were used in 
this study. The H4IIE cells were maintained in the minimum essential medium 
(MEM) with 0.1 mM nonessential amino acids and Earle's BSS, 80% fetal 
bovine serum (FBS), 10%; calf serum, 10%. The Clone 9 cells were 
maintained in Dulbecco's modified Eagle medium (DMEM) with 0.1 mM 
nonessential amino acids and Earle's BSS, 90%, fetal bovine serum (FBS), 
10%. 
2.3.2 Cytotoxicity test 
The cytotoxicity of TCMs was detected using Neutral Red assay. For 
each test of different TCMs, 1000 cells of H4IIE and Clone 9 cells were 
seeded on the 96-well plate. After 48 hours stabilization, different 
concentration of TCMs were added into wells of 96-well plate and PBS was 
added as control. Cells were washed with PBS twice after 5 days incubation. 
50 [i\ 0.5% (w/v) neutral red was added to each well and incubated for one 
hour (at 37 5% CO2 incubator). Plate was blotted dry after incubation and 
dried overnight in oven. On the next day, 100 pi 1% SDS was added to each 
well for lysis and the absorbance was read at 540nm by microplate reader 
(BioRad) using 1% SDS as blank. The percentage of viability was calculated 
from the equation - % viability = (1 -(control-sannple)/control)*100% 
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2.4 Screening of expressed gene induced by TCMs 
The H4IIE and Clone 9 cells were incubated with A.H, F.F., and R.C. for 
48 hours in 37 °C, 5% CO2 incubator. The total RNAs were harvested after 
incubation. The RNAs were used for reverse transcription, polymerase chain 
reaction, Northern blot analysis and cDNA expression array analysis. 
2.4.1 RNA preparation 
Total RNA was isolated from H4IIE and Clone 9 cells using TRIZOL 
reagent (Gibco BRL, Life Technologies, NY, USA). 1 ml of TRIZOL reagent 
was added to each well of culture and incubated for 3 minutes at room 
temperature. An aliquot of 200 pi of chloroform was then added and mixed 
vigorously. The mixture was allowed to stay in the room temperature for 10 
minutes and the reaction mixture was centrifuged at 12000 g at 4 °C for 10 
minutes. The aqueous phase was transferred into a clean tube and 500 pil of 
isopropanol was added prior to 10-minutes incubation at the room 
temperature. After incubation, centrifugation at 12000 g at 4 °C for 15 minutes 
was carried out. The RNA pellet was washed with 75% ethanol and air-dried at 
room temperature. The RNA pellet was redissolved in autoclaved DEPC-
treated water. The integrity of the RNA was checked using 1.5% 
formaldehyde/agarose gel. The concentration of RNA was calculated from 
absorbance at 260 nm recorded on a Beckman DU 650 spectrophotometer. 
Absorbance of 280 nm and 260 nm were recorded in order to check for the 
ratio of RNA to protein using the ratio of absorbance of 260 nm / absorbance 
of 280 nm. Absorbance of 340 nm was measured as the background. 
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2.4.2 cDNA array hybridization 
Two cDNA arrays of rat cDNA spotted on a nylon membrane (Altas Rat 
cDNA Expression Array, Clontech, Palo Alto, CA, USA) were used in this 
study. Two Altas arrays for rat cDNAs included rat stress/toxicology (207 
genes) and rat cDNA expression array (588 gene). The filters included the 
house keeping control cDNAs and negative controls spotted in duplicate dots. 
The glyceraldehydes 3-phosphate dehydrogenase (GAPDH) (M17701) was 
used as the housekeeping gene in this experiment. An amount of 10 pg of 
total RNAs were treated with DNAase I and poly A+ RNAs were collected 
according to the Altas array's protocol. The purified poly A+ RNAs were used 
for the preparation of cDNA probe. An aliquot of 6 pi of magnetic beads and 1 
M' of CDS primer mix (specific for each array, provided by the manufacturer 
Clontech, USA) were preheated in the Gene Amp® PGR system 9700 from PE 
Applied Biosciences at 65 °C for 2 minutes, then 50 °C for 2 minutes. To this 
preheated master mix (containing 4 pi reaction buffer, 2 pi dNTP mix, 5 jjI [a-
32p] dATP (3000 Ci/mmol, 10 mCi/ml, Amersham/Pharmacia Biotech, UK), 0.5 
Ml 100 mM DDT), 2 |j| MMLV reverse transcriptase (SOU /|j|) was added and 
incubated at 50 °C for 25 minutes. The reaction was terminated by adding 2 |j| 
10 X termination mix and incubated in the thermal cycler at 70 °C for 5 
minutes. The radioactively labeled cDNA was fractionated on a Chroma Spin-
200 column (Clontech Laboratories, USA) and the fractions that comprised the 
first peak of radioactivity were pooled for each cDNA synthesis reaction. The 
radioactively labeled probe was mixed with 1/10 total volume of 10X 
denaturing solution (1M NaOH, 10 mM EDTA) and incubated at 68 °C for 20 
minutes. After 20 minutes, 5 pi Cot-1 DNA and 1/2 total volume of 2X 
neutralization solution (1 M NaHsPCU’ pH 7.0) were added and continued for 
incubation at 68 °C for 10 minutes. The labeled probe was then added to 5 ml 
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prewarmed ExpressHyb solution (Clontech) with 0.5 mg of the sheared 
salmon testes DNA (Sigma, St. Louis, MO, USA) and mixed. This hybridization 
mixture was added to the Altas cDNA Expression Array membranes, which 
t 
were prehybridized in 10 ml of ExpressHyb Hybridization solution at 68 °C for 
30 minutes. The membranes were hybridized overnight with continuous 
agitation using oven from Bobbins Scientific at 68 °C. On the next day, the 
membrane were washed three times with the prewarmed wash solution 1 for 
30 minutes (2X SSC, 1% SDS), and once with wash solution 2 (0.1% SSC, 
0.5% SDS) with continuous agitation (12-15 rpm) at 68 °C. 2X SSC was used 
for the final wash for 5 minutes with agitation at the room temperature. The 
washed membranes were wrapped in plastic wrap and exposed the array to 
Kodak x-ray films at —80 °C with intensifying screens. 
For the analysis of the hybridization signals, the cDNA microarray 
autoradiograms were measured by densitometer from Molecular Dynamic and 
the signal were analyzed using the Image Quant NT software. The 
background signal was calculated based on the blank space between the 
different panels of the arrays and the signal threshold was set at the 
background-based signal threshold. Normalization of signal intensity was done 
by comparing signals from housekeeping control cDNAs. A report of 
differentially expressed genes was generated based on the ratio and the 
intensity difference. 
2.4.3 Reverse Transcription 
The first strand cDNA was synthesized using Superscript II (Gibco BRL, 
Life Technologies, NY, USA) for RT-PCR, 5 pi of RNA was used for the 
reverse transcription, 1 pi oligo (dT)i2-i8 and autoclaved DEPC treated water 
was added to a nuclease-free microcentrifuge tube to a volume of 12 pl.The 
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reaction mixture was heated in a thermal cycler at 70 °C for 10 minutes and 
then quick chilled on ice. Volumes of 4 pi 5X first strand buffer, 2 pi 0.1 M DTT 
and 1 Ml 10mM dNTP mix (10mM each dATP, dGTP, dCTP, dTTP at neutral 
pH) were mixed with the reaction mixture after brief centrifugation. The mixed 
contents were incubated in the thermal cycler at 42 °C for 2 minutes and then 
1 |jl of Superscript II (200 units) was added into the tube and mixed by 
pipetting gently up and down. The transcription was terminated after heating at 
70 °C for 15 minutes and the cDNA was obtained and used for the template 
for amplification of in PGR. 
2.5 Confirmation of expressed genes induced by TCMs 
Two different analysis were performed in order to confirm the results 
obtained from the cDNA expression array. Semi-quantitative PGR analysis 
and Northern blot analysis were carried out to verify results of expressed 
genes induced by TCMs. 
2.5.1 Semi-quantitative PCR analysis 
For the PCR analysis, a master mix was prepared prior to the 
amplification. This master mix included 10 X PCR buffer, 10mM dNTP mixture, 
50MM MgCl2, template DNA, primer mix (10 |JM each), Taq DNA polymerase 
(5 U/|jl) and autoclaved water. The tube was incubated in thermal cycler at 94 
。• for 3 minutes to completely denature the template DNA, and then 
performed PCR amplification. For each cycle, denatured the template at 94 °C 
for 45 seconds followed by annealing template at 55 °C for 30 seconds. The 
template was extended at 72 °C for 1 minute and 30 seconds, and incubated 
for an additional 10 minutes at 72 °C and maintained the reaction at 4 °C. The 
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amplified products were analyzed by 1.5 % agarose gel eletrophoresis using 
low mass DNA ladder ((Gibco BRL，Life Technologies, NY, USA) and 
visualized by ethidium bromide staining. The density of the PGR products was 
analyzed using UVIsoft UVband Windows Application v97.04 from UVI Tech. 
The primers sequences of GST Ya subunits (K01931) were GCC AGT 
GCT TCA CTA CTT CAA for the forward primer and TTC TTT TTG GTC TGG 
GGG ACA for the reverse primer. The sequences of GST 7-7 subunits 
(L29259) were TTT GAG TCC ACA CCT CTG TCT for the forward primer and 
CCA TAT TTG CAT CGA AGG TC for the reverse primer. The forward primer 
sequences of p21/cip1/waf1 (L41275) were AGT ATG CCG TCG TCT GTT 
CG and the sequences of the reverse primer were GAG TGC AAG ACA GCC 
ACA AG. For the DT-diaphorase (J02608), the forward primer sequences 
were ACT ACG ATC CGC CCC CAA CT and the reverse primer sequences 
were GGG CAC CCC AAA CCA ATA CA. For the growth-related c-myc-
responsive protein - rcl (U82591), the sequences of forward and the reverse 
primers were GTG TAG TTC TGC GGG AGC AT and AAA GTA CCG ATC 
GAG CAT GG, respectively. For the positive control, p-actin and GAPDH 
were used for the normalization. The primer sequences of p-actin were TTA 
AAA CGG TCT CAC GTC AGT G for the forward primer and CCA ACT CCT 
AAG GGG AGG AT for the reverse primer. For GAPDH, the forward primer 
sequences were ACC ACA GTC CAT GCC ATC AC, and the reverse primer 
sequences were TCC ACC ACC CTG TTG CTG TA. All primers were 
designed from the full-length mRNA sequences of specific genes. The 
specificity of primers was confirmed by the BLAST search. 
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2.5.2 Northern blot analysis 
Ten micrograms of total RNA were denatured and run on the 1.5% 
formaldehyde/agarose gel and the integrity of RNA were checked after 
ethidium bromide staining. The RNA was transferred onto Hybond N+ nylon 
membranes (NEN Life Science Products, Boston, USA) using 20X SSC by 
capillary force for 24 hours. The transferred RNA was immobilized by CL-1000 
UV crosslinker from UVP using 1200 J/cm .^ 
The probes for hybridization were purified from the PGR products of 
specific genes using Necleospin® Extraction (Clontech, Palo Alto, CA, USA) or 
using 2 |JM of reverse primers. The probes were radioactively labeled using 
Redivue [a^p] dCTP (AA0005, Amersham/ Pharmacia Biotech). An aliquot of 
30 |jl of probes was added to 15 pi of autoclaved water in a clean tube and 
boiled for 15 minutes for the denaturation. The boiled probes were kept on ice 
at once for 5 minutes. The denatured DNA was added into the rediprime 
labeling kit (Amersham/ Pharmacia Biotech) and 5 |j| of [a-^ P^] dCTP was 
added to the reaction tube. The DNA was mixed with the [a-^ P^] dCTP by 
pipetting up and down and the reaction mixture was incubated at 37 °C for 10 
minutes. 5 pi of 0.2M of EDTA was added to the reaction mixture for the 
termination. The radioactively labeled probes were denatured after heated at 
95 -100 °C for 5 minutes, and snap cooled on ice for 5 minutes. The probes 
were ready for use after chilled on ice for 5 minutes. 
Two different hybridization procedures were done in this study when 
using different probes for priming. The hybridization was carried out overnight 
when reverse primer of the growth-related c-myc-responsive protein - rcl was 
used. The hybridization was done at 42 °C for 16 hours. The membrane was 
washed twice with 2X SSC at room temperature for 5 minutes and then 
washed twice with wash solution 1 (2X SSC, 1% SDS) for 30 minutes at 42 
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°C. The membrane was washed twice with solution 2 (0.1 X SSC, 1% SDS) at 
room temperature for 30 minutes and rinsed with 2X SSC at room 
temperature. For the 2-hours hybridization, the hybridization temperature of 
GST Ya subunits, DT-diaphorase and GAPDH was 65 °C and hybridization 
temperature of GST 7-7 subunits and p21/cip1/waf1 was 60 °C. The 
hybridization was done at the specific hybridization temperature for 2 hours. 
The membrane was washed with wash solution A (2X SSC. 0.1% SDS) for 20 
minutes and then washed twice with wash solution B (0.2X SSC, 0.1% SDS) 
for 15 minutes at hybridization temperature. The washed membrane was then 
rinsed with 2X SSC. The hybridized membrane was wrapped in plastic wrap 
with 2X SSC. The autoradiography was done on Kodak X-ray film with 
intensifying screen at - 80 °C. 
2.6 Studies of effects of TCMs on gene expression 
Different TCMs had different effects on gene expression. The time-
course and the dosage-course studies on gene expression were performed. 
2.6.1 Dosage-course study 
For each TCM, different concentrations were used to study the effects 
of TCMs as well as active components on the gene expression level. The 
concentrations were designed from the result of cytotoxicity test of the cell 
viability. The concentrations of TCMs or active constituents used for the study 
were lower than LC50 to minimize to cytotoxic effects of these constituents to 
the H4IIE and Clone 9 cells. In this study, 5x 10® of H4IIE/ Clone 9 cells were 
seeded on a 100mm TC treated tissue culture plates. Cells were kept in the 37 
°C, 5% CO2 incubator for 48 hours for the stabilization. TCMs and other 
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constituents were diluted from the stock solution using PBS, and the PBS was 
used as the control. Cells were incubated for 48 hours and RNA were 
extracted according to 2.4.1. The extracted RNA was used for the RT-PCR 
analysis and Northern blot analysis to study the dosage-course effects of 
TCMs. 
2.6.2 Time-course study 
For each concentration of TCMs, incubation for different durations was 
done. Cells were seeded on 100 mm tissue culture plate and time-course 
treatment was performed after stabilization for 48 hours. Plates were 
incubated for 8，16，24 and 48 hours and RNA were extracted from treated 
cells. The effects of TCMs and its constituents on the gene expression were 
studied by RT-PCR analysis and Northern blot analysis. 
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3.1 Cytotoxicity test of A.H,, R.C. and F.F. 
The toxicity of A.H., R.C. and F.F. to cell viability in normal hepatocytes 
and hepatoma cells were studied. The aqueous extracts of these herbs were 
employed in the neutral red assay. In this study, the effects of active 
constituents of A.H. and R.C. on cell viability were analyzed as well. The 
effects of these herbs of the cell viability were measured and the percentage 
of cell viability of two different cell-lines after treatment of A.H., R.C. and F.F. 
was shown in figure 3.1, 3.3 and 3.5, respectively. Figures 3.2，3.4 indicated 
the cytotoxic effects of L-abrine and berberine, respectively. In this test, the 
difference of LC50 between Clone 9 and H4IIE showed the ability of the tested 
TCMs and its constituents in inhibition of growth of cancer cells. 
From the Neutral Red assay, A.H. was effective in retarding the rate of 
cell growth of H4IIE when compared with Clone 9 cells. The LC50 of the A.H. is 
350 |jg/ml and 600 |jg/ml in H4IIE and Clone 9 cell, respectively. The 1.714-
fold difference of LC50 showed the inhibitory effects of A.H. in cancer cell 
growth. When the cytotoxicity of L-abrine and choline were tested, results 
indicated that it was not effective in inhibiting the cell growth of H4IIE cells. 
The difference of LCsowas 2.4 fold in the treatment of L-abrine. However, the 
Clone 9 cells was more sensitive to the treatment of these constituents and 
killed in a lower concentration. 
The LC50 of R.C. was 50 pg/ml and 150 pg/ml in H4IIE and Clone 9 
cells, the 3-fold difference in LC50 indicated the effectiveness of growth 
inhibiting effects of cancer cells. Berberine also showed similar effects on 
cells. There was 2.14-fold different in LC50 when berberine was used for the 




For the F.F., the cytotoxicity of this herbal medicine was studied. There 
was more than 4-fold difference in LCsowhen comparing the percentage of cell 
viability. The anticancer activity of this herb in the cell growth level was most 
significant and effective among TCMs used in this study. 
A.H. L-abrine R.C. berberine F ^ 
H4IIE 350 |jg/ml 601jM 50 pg/ml TOI jM 240 |jg/ml 
Clone 9 600 i^g/ml 25 pM 150 [jg/ml 150 |JM 1000 pg/ml 
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Figure 3.1 The cytotoxicity of the aqueous extracts of Abri Herba in H4IIE 






80 - \ M 
1 �\f \ 
> 60 - \ \ 
1 丄 \ v 
承 � \ 
I 、入 
0 1 I i I I I J I  
0 20 40 60 80 100 120 140 concentration (|jM 
旧-蜃 一 Clone 9 
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3.2 Molecular screening of expressed gene induced by 
A.H•，R.C. and F.F. 
The effects of the aqueous extracts of A.H., R.C. and F.F. on the gene 
expression level were examined using cDNA array. Genes that were related to 
stress responses and cell cycle control became the target of studies. The 
effects of the herbal extracts were studied using the rat cDNA expression 
array system and the expression level of different mRNA in the treated cells 
was identified. The expression pattern of the array was shown in figure 3.6 -
3.8 for A.H•，R.C. and F.F., respectively. The mRNA expression level of genes 
was up regulated from 2.4 to 3.2 fold when cells were treated with A.H., 1.2 to 
1.8-fold change in expression level of RNA when R.C. was used for the 
treatment. The expression level of mRNA in F.F. treatment cells was regulated 
from 2.6 to 6.2 fold. The identity of the expressed genes and level of gene 
expression were listed in Table of 3.1 to 3.3. 
In order to characterize the hepatoprotective effects of these herbs, the 
mRNA of the treated cells were used for the hybridization of gene array. In this 
case, the A.H. and the R.C. were selected for further investigation because the 
induction effect on the gene expression was more significant. The rat 
toxicology II was used for studies. The procedure of the array was the same 
as those when using rat cDNA expression array system and the expression 
patterns of the toxicology array for the A.H. and the R.C. were shown in figure 
3.9 and 3.10. The expression level of mRNA changed from 2.1 to 4.7 fold and 
2.1 to 8 fold when A.H. and R.C. were used, respectively. The details of the 
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Accession number Gene/protein name Ratio (fold) Coordinate 
Area B (Stress Response, Ion channels and transporter, modulator, effectors and 
intracellular transducer) 
D30041 Rac-beta serine/threonine protein kinases 3.8 up b2l 
Area C (Apoptosis, DNA synthesis, repair and recombination) 
M87854 G protein p-adrenergic receptor kinase 1 2.5 up c3k 
M20713 GTP-binding protein; G-a-i3 4 up c3n 
Z11558 Glia maturation factor p (GMF-p) 2.8 up c6i 
Area D (Transcription factors, DNA-binding proteins) 
U76205 Scavenger receptor class B type I 2.6 up dl j 
Area E (Receptors, cell surface antigens, cell adhesion) 
J04811 Growth hormone receptor 2.5 up e2i 
Area F (Cell-cell communication, cytoskeleton and motility and protein turnover) 
X83537 Matrix metalloproteinase-14 precursor 2.4 up f4d 
Table 3.2 The identity of genes in rat cDNA expression array induced by 
A.H. treated H4IIE cells. 
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Figure 3.7 The gene expression profile of rat cDNA expression array after 
hybridization with mRNA collected from R.C. treated H4IIE cells. 
The upper panel showed the gene expression pattern of control, 
the lower panel showed expression profile of R.C. treated cells 
(20 Mg/ml) 
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Results 
Accession number Gene/protein name Ratio (fold) Coordinate 
Area A (Oncogenes, tumor suppressors and cell cycle regulator) 
AF003926 Ear-2; rCOUPg; v-erbA related proto- 1.6 down a2g 
oncogene ^ 
U09793 c-K-ras 2b proto-oncogene 1.3 down a4f 
X93591 MSN2 DNA mismatch repair protien 1.2 up a6m 
Area C (Apoptosis, DNA synthesis, repair and recombination) 
D82363 Presenilin-1(PS1) 1.5 up c2m 
Area F (Cell-cell communication, cytoskeleton and mobility and protein turnover) 
M89791 Insulin-like growth factor binding protein 1 1.5 up a1a 
precursor 
M32247 a-1 antitrypsin 1.8 up f4j 
Table 3.3 The identity of genes of rat cDNA expression array induced by 
the treatment of H4IIE cells with R.C. 
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Figure 3.8 The gene expression pattern of rat cDNA expression array after 
hybridization of mRNA from F.F. treated H4IIE cells (lower panel) 
and the control (upper panel). 
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Accession number Gene/protein name Ratio (fold) Coordinate 
Area C (Apoptosis, DNA synthesis, repair and recombination) 
X02904 Glutathione S-transferase TT subunit (GST 2.6 up d m 
subunit 7 TT) 
Area D (Transcription factors, DNA-binding proteins) 
L29259 Elongation factor SHI P15 subunit 6.2 up d5c 
Area F (Cell-cell communication, cytoskeleton and mobility and protein turnover) 
M89791 Insulin-like growth factor binding protein 1 3.2 up f1a 
precursor 
Table 3.4 The identity of genes of rat cDNA expression array induced by 
the treatment in H4IIE cells with F.F. 
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Figure 3.9 The gene expression pattern of A.H. treated H4IIE cell (lower 
panel) and the control (upper panel) from rat toxicology array II 
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Results 
Accession Gene/protein name Ratio Coordinate 
number (fold) 
Stress response regulators & effectors 
Z16415 MAP kinase kinase 1 3.8 up 31 
U82591 Growth-related c-myc-responsive protein; rcl 4 up 4j 
L14680 Apoptosis regulator bcl-2 4.5 up 4m 
U72350 Apoptosis regulator bcl-x 2.9 up 4n 
L24804 p23; 23-kDa progesterone receptor-associated 6.6 down 6h 
protei � 
U83843 T-complex protein 1 eta subunit (TCP-1-eta) 2.8 up 7c 
J02608 DT-diaphorase; quinone reductase 2.9 up 8e 
L02121 Cyclin-dependent kinase 5 (CDK 5) 2.1 up 9e 
D16309 G1/S-specific cyclin D3 3 up 9m 
L41275 p21 ； cip; waf1 2.2 up 10d 
M20035 Prothymosin-a 2.3 up 10k 
Nucleotide excision repair 
M95809 Basic transcription factor 62-kDa subunit 4.7 up 12j 
Homologous recombination 
D13804 RecA-like protein HsRad51 2.2 up 14d 
M62388 17-kDa ubiqitin-conjugating enzyme E2 4.2 down 14h 
Mismatch repair 
X93591 MSH2 DNA mismatch repair protein 2.3 up 15g 
Table 3.5 List of genes of rat toxicology/stress array induced by the 
treatment of H4IIE cells with A.M.. 
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Figure 3.10 The gene expression pattern of R.C. treated H4IIE cell (lower 
panel) and the control (upper panel) from rat toxicology array II 
-67-
Results 
Accession Gene/protein name Ratio Coordinate 
number (fold) 
Stress response regulators & effectors 
U82591 Growth-related c-myc-responsive protein; rcl 8 up 4j 
U72350 Apoptosis regulator bcl-x 4 up 4n 
D16237 M-phase inducer phosphatase 2 4 up 8n 
D16309 G1/S-specific cyclin D3 2.4 up 9m 
D14015 G1/S-specific cyclin E 4.2 up 9n 
M20035 Prothymosin-a 2.1 up 10k 
DNA damage response, repair & recombination 
L02121 Purine-rich single-stranded DNA-binding 2.6 up 10m 
protein a 
Nucleotide excision repair 
L41275 Replication protein A 32 kDa subunit 3.6 up 12k 
Homologous recombination 
D13804 Rec-A-like protein HsRad 51 2.1 up 14d 
Mismatch repair 
X93591 MSH2 DNA mismatch repair protein 2.5 up 15g 
Drug & xenobiotic metabolism 
K01931 Glutathione S-transferase Ya subuinit 5.6 up 17f 
Table 3.6 List of genes of rat toxicology/stress array induced by the 
treatment of H4IIE cells with B.C. 
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In the treatment of Abri Herba, the transcription of genes in H4IIE cells 
was induced. Seven genes from the cDNA expression array were increased in 
mRNA expression level and 15 genes were changed in the mRNA 
transcription level in different extent. Among 22 genes, the expression level 
changed from 6.6-fold down regulation to 4.5-fold up regulation. Genes related 
to the stress response regulators or effectors were induced in a most 
significant percentage. From the results of the toxicology/ stress array, the DT-
diaphorase and p21; cip;waf1 were induced by 2.9 and 2.2 fold, respectively. 
DT-diaphorase was responsible for the reduction of the quinone to 
hydroquinone in a single two-electron step. This obligate two-electron 
reductase was abundant in the liver and useful in yielding substrate for phase 
II conjugation as well as to protect against the oxidative damage. The 
p21 ；cip;waf1 increased 2.2 fold in the mRNA expression after treatment of 
A.H. in H4IIE cells. This cycilin-dependent kinases inhibitor controlled the 
progression of cell cycle and thus may play a role in the inhibition of cell 
growth of H4IIE after the A.H. treatment. 
From the results of the array of R.C. treated cells, 6 genes and 11 
genes were induced in H4IIE cells from rat cDNA expression array and rat 
toxicology/stress array. The mRNA expression level of induced genes from rat 
cDNA expression array was moderately increased. The expression level 
ranged from 1.6-fold down regulation to 1.8-fold up regulation. From the 
toxicology/stress array, genes were induced from 2.1 fold to 8 fold differently. 
The glutathione S-transferase Ya subunit and growth-related c-myc-
responsive protein rcl were induced 5.6 fold and 8 fold, respectively. GST Ya, 
is an abundant phase II enzyme found in liver and responsible for the 
detoxfication of various xenobiotics and prevents the inhibition of bilirubin to 
other classes of GST by the effective binding of this compound. 
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The growth-related c-myc-responsive protein rcl is responsible for the 
stimulation of the growth system of regenerating liver and plays a role in 
growth control during cell proliferation. The increase of this mRNA expression 
(8-fold) indicated treatment of Abri Herba triggered a growth control machinery 
to achieve the hepatoprotection function. 
Treatment of F.F. in H4IIE induced 3 different genes, glutathione S-
transferase 7-7，elongation factor Sill P15 subunit and insulin-like growth 
factor binding protein 1. They were 2.6，6.2 and 3.2 fold induced after 
treatment. Among these three genes, only the GST 7-7 was involved for the 
protection machinery of liver or other xenobiotics from outside. 
3.3 Confirmation of expressed genes using semi-
quantitative RT-PCR 
As the a-32p dATP was used for the labeling in cDNA array system, the 
spreading effects of the radioactivity of a-^ P^ dATP may affect the sensitivity of 
the expression array. Thus the semi-quantitative RT-PCR was used for the 
confirmation of the expressed genes that were induced by treatment of various 
TCMs in this study. 
3.3.1 Dosage-course and time course studies of A.H. using 
RT-PCR 
In the treatment of A.H., p21;cip;waf1 the and DT-diaphorase were 
induced in H4IIE cells. The dosage and the time-course effects of this herb 
was identified using RT-PCR and Northern blot analysis in order to estimate 
the effectiveness of A.H. in hepatoprotective function. 
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(i) Study of A.H. in the expression level of P21 ；cip;waf1 
From the results of the RT-PCR, the expression level of p21 ;cip;waf1， 
was increased in a dosage-dependent manner. The expression of this gene 
increased from 1.79 to 2 fold when compared with the control in H4IIE cells in 
different incubation time. The Clone 9 cells were also studied as the counter 
part of the cancer cells to identify the different effects of A.H. on cancer and 
normal liver cells. The p21;cip;waf1 expression level also increased in a 
dosage-dependent manner with a less extent of expression level. The gene 
was induced 1.43 to 1.75 fold at different time period. 
In the time-course study of the p21 ；cip;waf1, results indicated that 
treatment of A.H. would increase the expression of p21 ；cip;waf1 from 8 to 48 
hours and the expression level maintained at 2-fold induction. No obvious 
difference was found in H4IIE cells during the time-course treatment. In Clone 
9 cells, the expression level was increased by a lower extent when compared 
with those in H4IIE cells. The expression of p21 seemed to be affected by the 
prolonged treatment of A.H. The expression level reached maximum when the 
incubation increased to 48 hours. Figure 3.11 to 3.14 showed the dosage and 
time-course effects of A.H. on the gene expression in P21;cip;waf1 in H4IIE. 
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(ii) Study of active constituent — L-abrine in the expression level of 
P21 ;cip;waf1 
From the results of the study of RT-PCR on the expression level of 
p21;cip;waf1, this gene was induced from 1.59 to 2.20 fold in H4IIE cells and 
the expression level increased in a dosage-dependent and time-dependent 
manner when compared with the control. The expression level of p21 
increased and maintained at high expression level after 16-hour incubation. 
Figure 3.19 to 3.22 showed the results of the study. 
The effects of L-abrine in Clone 9 cells on the expression of p21 in 
Clone 9 cells also have an inductive function in the mRNA expression of this 
gene. The expression of mRNA of p21 increased to 1.80 fold after 8-hour 
incubation and the expression of this gene reduced as the incubation time 
increased. The expression level diminished to 1.38 fold induction as the 
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(Hi) Study of A.H. in the expression level of DT-diaphorase 
From the study of the mRNA expression of DT-diaphorase, treatment of 
cells with A.H. can induce the DTD expression in both Clone 9 and H4IIE cells. 
DTD increased 2.27 fold in H4IIE and 1.3 fold in Clone 9 cells after 8-hour 
incubation. Effects of the A.H. on the DTD mRNA expression seemed to last 
for a short term because of the inductive effects of DTD expression diminished 
as the incubation time increased. Changes in concentration of A.H. showed a 
marked influence of DTD expression. The expression of DTD increased as the 
concentration increased in H4IIE cells, however this dosage-dependent effects 
of A.H. diminished as the incubation time increased. In Clone 9，DTD also 
exhibited a dosage-dependent manner, but the expression of DTD reduced as 
the incubation time increased. The expression level of this gene was 
decreased by the treatment with A.H. Figure 3.27 and 3.28 showed the effects 
of A.H. on DTD expression in both cell lines. 
(iv) Study of L-Abrine in the expression level of DT-diaphorase 
Treatment of L-abrine showed similar effects of those in the treatment 
of A.H. The expression level of DTD in Clone 9 increased to 1.3 fold as the 
concentration increased to 40 |JM and this effect was diminished and then 
reversed when the incubation time increased to 48 hours. The expression 
level of DTD decreased to 0.65 fold when compared with the control. In H4IIE 
cells, inductive effects of L-abrine became more obvious. The mRNA level 
increased as the concentration increased and the expression level increased 
to 1.46 fold after 48 hour treatment. DTD showed a dosage and time-
dependent manner when L-abrine was used for the treatment of H4IIE cells. 
The mRNA level increased as time or dosage increased. Figure 3.29 and 3.30 
showed the effects of L-abrine on the DTD expression. 
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Figure 3.28 The dosage and time-course effects of A.H. on DTD expression 
in Clone 9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.29 The dosage and time-course effects of L-abrine on DTD 
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Figure 3.30 The dosage and time-course effects of L-abrine on DTD 
expression in clone 9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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3.3.2 Dosage-course and time course effects of R.C. using RT-
PCR 
In the treatment of R.C. growth-related c-myc-responsive protein, rcl 
and GST Ya subunit were induced in H4IIE cells. Effects of this herb were 
identified using RT-PCR and Northern blot analysis in order to study the 
functions of R.C. in the liver. 
(i) Expression level of growth-related c-myc-responsive protein, rcl after 
treatment of R.C.. 
In treatment of H4IIE cells with R.C•，the mRNA level of rcl increased as 
the concentration increased and reached the maximum level of 2.13 fold when 
compared with the control (figure 3.31). The mRNA expression level of rcl also 
increased 2.06 fold when Clone 9 cells were used for study (figure 3.32). The 
expression of mRNA remained at a high level when the cells were treated with 
the aqueous extracts of R.C. in both cell lines. Duration of incubation with drug 
affected the rcl expression. The effects of R.C. were most effective in inducing 
the rcl expression when the incubation time increased to 8 to 16 hours and this 
effect diminished when the prolonged treatment was carried out. Fixed 
concentration (20 |jg/ml) of the extracts was used in the time-course study. 
The rcl expression was induced 1.74 fold compared with 4-hour incubation in 
H4IIE cells at 16-hour incubation (figure 3.35) and 1.52 fold difference was 
found when cells was incubated for 8 hours in Clone 9 cells (figure 3.36). 
(ii) Expression level of growth-related c-myc-responsive protein，rcl after 
treatment of berberine. 
Studies of the effects of berberine also carried out in order to identify the 
function of R.C. Berberine was selected for this study and the results of 
dosage-course study indicated that treatment of berberine increased the 
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mRNA expression of rcl in H4IIE cells but decreased the expression level in 
Clone 9 cells. The rcl expression was induced to 2.23 fold in H4IIE (figure 
3.33) but reduced 0.35 fold (figure 3.34) in Clone 9 cells when compared to 
the corresponding control. Time-course study showed that berberine had the 
short-term inductive effects of rcl in both H4IIE (figure 3.37) and Clone 9 cells 
(figure 3.38). The expression level reached the maximum when incubated with 
berberine for 24 hours and 16 hours in H41IE and Clone 9 cells, respectively. 
The expression level reached the maximum level of 1.96 and 2.47 fold in 
H4I旧 and Clone 9 cells. 
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Figure 3.34 The dosage-course effects of berberine on growth-related c-myc-
responsive protein; rcl expression in Clone 9 cells using RT-
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Figure 3.34 The dosage-course effects of berberine on growth-related c-myc-
responsive protein; rcl expression in Clone 9 cells using RT-
PCR. (*P<0.05; **P<0.005) 
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Figure 3.34 The dosage-course effects of berberine on growth-related c-myc-
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Figure 3.37 The time-course effects of berberine on growth-related c-myc-
responsive protein; rcl expression in H4IIE cells using RT-PCR.( 
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Figure 3.34 The dosage-course effects of berberine on growth-related c-myc-
responsive protein; rcl expression in Clone 9 cells using RT-
PCR. (*P<0.05; **P<0.005) 
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(Hi) mRNA expression level of GST Ya subunit after treatment of R. C 
The mRNA expression level of GST Ya increased 1.48 and 2.09 fold in 
a dosage-dependent manner in H4IIE and Clone 9 cells, respectively. In this 
study, cells were incubated with the aqueous extracts of R.C. and the 
expression level of GST Ya was determined using RT-PCR. Results indicated 
that expression level of GST Ya mRNA was inducible by the treatment of R.C. 
and the effects of the GST Ya induction was concentration-dependent. The 
results of the dosage-course study were showed in figure 3.39 and 3.40. The 
expression level increased as the incubation time increased. The expression 
level of GST Ya was induced to 1.52 fold in H4IIE cells after 48-hour 
incubation (figure 3.43) and the expression level increased to 1.66 fold in 
Clone 9 cells after 24 hours treatment (figure 3.44). 
(iv) mRNA expression level of GST Ya subunit after treatment of berberine 
Effects of berberine on GST Ya expression were more significant 
(P<0.005). The expression level increased 2.71 and 2.02 fold in H4IIE and 
Clone 9 cells, respectively. The expression level of GST Ya remained at 2 fold 
increase when the concentration increased from 5 |jg/ml to 20 pg/ml. 
Expression level increased more significantly (P<0.005) when compared with 
the treatment of R.C., but the level of the expression was not concentration-
dependent. The results of the GST Ya expression induced by berberine were 
showed in figure 3.41 and 3.42. Different incubation periods of time with 
berberine increased the expression of GST Ya to 1.81 and 1.78 fold in H4IIE 
and Clone 9 cells, respectively (figure 3.46’ 3.47). mRNA of GST Ya was 
increased in a proportional fashion in H4IIE cells. The effects of berberine 
increased the GST Ya expression level to the maximum after 24-hour 








1.400 - r ^ ^ 
T t ^ o 
1.200 - 『C、 、》。 
35 _ _ 二 “ 
r 。 。 。 - 网 _ _ _ 
a _ _ _ � 
芸 0.800 - 豫 闺 a C： ； •： 
^ S H B ；：足：； 
0.600 - ^ tf - “ •、：. 
b ^ 教、\ ：、, 
u.^ uu U 二 ， 胃 ^ t i ^^  字： 、； 麵 备 钱 、 
0 遷 — 7 ：^  、 
：^ \ ： 。心 ：、 
0.000 i S j J ‘：」 I , I.::.....1 , ..... , 
Control 2.5 5 10 20 
Concentration (pg/ml) 
Figure 3.39 The dosage-course effects of R.C. on GST Ya expression in 
H4IIE cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.40 The dosage-course effects of R.C. on GST Ya expression in 
Clone 9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.41 The dosage-course effects of berberine on GST Ya expression 
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Figure 3.42 The dosage-course effects of berberine on GST Ya expression 
in Clone 9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.43 The time-course effects of R.C. on GST Ya expression in H4IIE 
cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.44 The time-course effects of R.C. on GST Ya expression in Clone 
9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.41 The dosage-course effects of berberine on GST Ya expression 
in H4IIE cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.46 The time-course effects of berberine on GST Ya expression in 
Clone 9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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3.3.3 Dosage-course and time course effects of F.F. using RT-
PCR 
In the treatment of H4IIE and Clone 9 cells with Fructus Forsythiae, 3 
genes were induced by this herbal medicine. The GST 7-7 was the only 
detoxifying enzyme induced by the treatment; thus, the effects of the F.F. on 
the GST 7-7 were further analyzed by RT-PCR. 
(i) Dosage-course study of GST 7-7 expression level induced by F.F. 
The expression of GST 7-7 was induced 1.93 and 1.65 fold in H4IIE 
and Clone 9，respectively. The expression of this gene showed a 
concentration-dependent manner when the F.F. was used to treat both cell 
lines. Effects of F.F. were more significant (P<0.005) in H4IIE cells when 
compared with the normal counterpart. The gene expression in both cell lines 
showed a correlation between GST 7-7 expression and the concentration of 
F.F. The results were shown in figures 3.47 and 3.48 for H4IIE and Clone 9 
cells. 
(ii) Time-course study of GST 7-7 expression in H4IIE and Clone 9 cells 
induced by F.F. 
Time-course study of F.F. indicated that GST 7-7 increased in 
expression after 16 to 24-hour incubation in both cells lines. In this study, 800 
Mg/ml of F.F. was used for treatment. Expression of GST 7-7 increased 2.54 
fold in H4IIE cells when cells were incubated with F.F. for 24 hour. Inductive 
effect of F.F. diminished when prolonged treatment occurred (figure 3.49). In 
Clone 9 cells, the time-course effects of F.F. were similar to those of H4IIE 
cells, expression of GST 7-7 increased to 1.97 fold after 16-hour incubation of 
F.F. Decrease in inductive effects of F.F. in Clone 9 cells occurred after 24 
hours treatment (figure 3.50). 
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Figure 3.42 The dosage-course effects of berberine on GST Ya expression 
in Clone 9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.48 The dosage-course effects of F.F. on GST 7-7 expression in 
Clone 9 cells using RT-PCR. (*P<0.05; **P<0.005) 
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Figure 3.44 The time-course effects of R.C. on GST Ya expression in Clone 
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3.4 Conf i rmat ion of expressed genes using Northern blot 
analysis 
There are limitations in confirming gene expression level using RT-
PCR. Numerous preparation procedures involved in RT-PCR may amplify the 
errors of the semi-quantitative study of RT-PCR; thus, Northern blot analysis 
was applied to confirm the results of cDNA array. Together with the results 
from RT-PCR, the gene expression induced by TCMs can be confirmed. 
3.4.1 Dosage and time-course studies of effects of A.H. and L-
abrine in Northern blot analysis 
In this part of study, a-^ P^ dCTP was applied as a labeling tag in order 
to confirm the gene expression of p21;cip;waf1 and DT-diaphorase which 
were inducible by aqueous of A.H. and L-abrine. 
(i) Dosage and time-course effects of A.H. on gene expression of 
p21;cip;waf1 
The mRNA expression of p21 ；cip;waf1 can be directly determined by 
the Northern blot analysis. The expression level of p21 was increased more 
than 2 fold when compared with the control. Expression of this increased as 
the concentration of A.H. increased. Induction effect A.H. on p21 was time-
dependent as the maximum expression increased when the incubation time 
increased. Prolonged treatment with A.H. of H4IIE cells can induce p21 
expression (figure 3.51). In Clone 9 cells, the inductive effect of A.H. on p21 
expression was most significant (P<0.005) after 8-hour incubation and the 
effect diminished when the incubation time increased. The expression of p21 
also showed a dosage-dependent fashion when the aqueous extracts were 
used to treat Clone 9 cells (figure 3.52). 
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Figure 3.54 Northern blot analysis of the dosage and time-course effects of 
L-abrine on P21 ；cip;waf1 in Clone 9 cells. (*P<0.05; **P<0.005) 
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Figure 3.54 Northern blot analysis of the dosage and time-course effects of 
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W) Dosage and time-course effects of L-abrine on gene expression of 
P21 ;cip;waf1 
In the study of the effects of L-abrine on gene expression, results 
indicated that treatment of L-abrine could induce p21 to 1.79 fold after 8 hours 
and 2.07 fold after 48 hours. Data showed that mRNA level of p21 increased 
in time and dosage dependent manner. This result indicated that treatment of 
L-abrine could interfere the transcription of p21 gene in H4IIE cells (figure 
3.53). Effects of L-abrine in Clone 9 cells showed similar results in dosage-
course study. The mRNA expression level increased 1.96 fold when compared 
with the control. However, the results of time-course study showed that 16-
hour incubation of L-abrine was more effective in inducing the p21 mRNA 
expression. Reduction in mRNA expression occurred when the incubation time 
increased (figure 3.54). 
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Figure 3.54 Northern blot analysis of the dosage and time-course effects of 
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Figure 3.54 Northern blot analysis of the dosage and time-course effects of 
L-abrine on P21 ；cip;waf1 in Clone 9 cells. (*P<0.05; **P<0.005) 
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W) Dosage and time-course effects of A.H. and L-abrine on gene 
expression of DT-diaphorase 
The expression of DT-diaphorase mRNA was determined in order to 
compare the results of RT-PCR analysis. In the treatment of cells with A.H., 
the expression of DT-diaphorase increased most significantly (P<0.005) at 8-
hour incubation. The expression of DTD increased 2.19 and 2.51 fold in H4IIE 
and Clone 9 cells, respectively (figure 3.55，3.56). Results also indicated that 
inductive effects with A.H. in both cell lines decreased and the expression 
level of DTD decreased in Clone 9 cells when compared with the control after 
prolonged incubation with A.H. These data showed that Clone 9 cells was 
more sensitive to the treatment with A.H. in the expression of DTD when 
compared to the results collected from H4IIE cells. 
Treatment of H4IIE cells with L-abrine induced the expression of DTD 
after 48-hour treatment. The expression of DTD increased 2.7 fold when 40 
fjM of L-abrine was used to treat the H4IIE cells for 48 hours (figure 3.57). L-
abrine can induce the expression of DTD in Clone 9 also, but the inductive 
effects on the DTD expression decreased as the incubation time increased. 
The DTD expression level increased to the maximum level of 1.94 fold and 
then decreased to 0.57 fold after 48-hour incubation when compared with the 
control (figure 3.58). 
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3.4.2 Dosage and time-course studies of effects of R.C. and 
berberine in Northern blot analysis 
(i) Dosage and time-course effects of R.C. and berberine on gene 
expression of growth-related c-myc-responsive protein; rcl. 
Inductive effects of R.C. on the mRNA level of c-myc-responsive protein; 
rcl was determined in both H4IIE and Clone 9 cell lines. Results of Northern 
blot analysis indicated that treatment of R.C. on H4IIE cells could induce the 
rcl mRNA expression in response to the increase of the concentration. The 
expression of rcl increased 2.10 fold when H4IIE cells were incubated with 10 
Mg/ml of R.C. (figure 3.59). In Clone 9 cells, treatment with R.C. also showed a 
significant increase in rcl mRNA expression (1.86 fold). However the 
expression level of this gene did not show any trend or relationship between 
the concentration and the expression level (figure 3.59). When berberine was 
used to treat H4IIE and Clone 9 cells, the expression level of rcl increased 
2.23 fold in H4IIE cells. The treatment of H4IIE with berberine was 
concentration dependent at lower concentration (figure 3.61). In Clone 9 cells, 
the time-course effects of berberine in rcl expression showed opposite results 
to those in H4IIE cells. The expression of rcl reduced to 0.13 fold when 
compared to the control as the concentration increased (figure 3.62). 
Time-course effects of R.C. and berberine on rcl expression were 
studied by Northern blot analysis. The results showed that both R.C. and 
berberine could induce rcl expression in short term. Prolonged treatment of 
these substances diminished the rcl expression in both H4IIE and Clone 9 
cells (figure .363 -3.66). 
-129-
Results 
I I H I • • • • • 
Control 2.5 5 10 20 (pg/ml) Control 2.5 5 10 20 (pg/ml) 




2.00 - — n , T , 
� T ; : 一： 
18 H n 1 L • 7 
•i 1.50 - T ---- -么, 
° r ^ --「-
o . 
1.00 - : 
1 ； : ； - ； 
、 ^ I \ 
。.5。_ ‘ ：：., t:丨 \ :::: 
0.00 _ _ L _ 1 _ _ _ , 」 , L - f l . U L J 
Control 2.5 5 10 20 
Concentration (pg/ml) 
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Figure 3.63 Northern blot analysis of the time-course effects of 10 J.,Jg/ml of 
R.C. on c-myc-responsive protein; rei expression in H411E cells. 
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berberine on c-myc-responsive protein; rcl expression in H4IIE 
cells. (*P<0.05; **P<0.005) 
-136-
Results 
… … IIII IIiH_“^feriiiiiiiii • i f t H i i 書 mSKKttf^ t ^ f f f wmm 




2 . 5 0 � 
2 . 0 0 - •• 
① 
S 1.50 - T 
① o  
c 丄 




0.00 I I I , I I I , 
Control 8 16 24 48 
Incubtion time (hours) 
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(ii) Dosage and time-course effects of R.C. and berberine on gene 
expression of GST Ya subunit. 
Besides rcl, GST Ya subunit was also studied in this analysis. From the 
results of dosage-course study of R.C., the expression of GST Ya subunit 
showed concentration-dependent with the induction level. Incubation of R.C. 
could increase 2.10 and 2.52 fold in H4IIE and Clone 9 cells (figure 3.67,3.68). 
This result indicated that incubation of R.C was more effective in inducing GST 
Ya in Clone 9 cells. The dosage-course effect of berberine was similar to 
those of R.C. The expression of GST Ya could be induced by treatment of 
berberine. This effect was significant at concentration of 10 |jg/ml as the 
expression level of GST Ya increased 1.72 and 2.14 fold in H4IIE and Clone 9 
(figure 3.69，3.70). 
In the study of time-course effects of R.C. and berberine on H4IIE and 
Clone 9 cells, the results indicated that treatment of both berberine and R.C. 
could increase the GST Ya expression in short term (figure 3.71-3.73). 
Inductive effect of gene expression reduced and the expression level 
diminished. However in H4IIE cells, incubation of berberine could induce 
consecutive expression of GST Ya to 1.96 fold when H4IIE cells was 
incubated with berberine for 48 hours (figures.73). 
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Figure 3 .70 Northern blot analysis of the dosage-course effects of berberine 
on GST Ya expression in Clone 9 cells. (*P<0.05; **P<0.005) 
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Figure 3.70 Northern blot analysis of the dosage-course effects of berberine 
on GST Ya expression in Clone 9 cells. (*P<0.05; **P<0.005) 
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Figure 3.70 Northern blot analysis of the dosage-course effects of berberine 
on GST Ya expression in Clone 9 cells. (*P<0.05; **P<0.005) 
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Figure 3.71 Northern blot analysis of the time-course effects of R.C. on GST 
Ya expression in H411E cells. (*P<O.05; **P<O.005) 
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Figure 3.70 Northern blot analysis of the dosage-course effects of berberine 
on GST Ya expression in Clone 9 cells. (*P<0.05; **P<0.005) 
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Figure 3.73 Northern blot analysis of the time-course effects of berberine on 
GST Ya expression in H4IIE. (*P<0.05; **P<0.005) 
- 1 4 5 -
Results 
11IM 







g 1.20 — 









0.00 1 i I I ) 
Control 8 16 24 48 
Incubation time (hours) 
Figure 3.70 Northern blot analysis of the dosage-course effects of berberine 
on GST Ya expression in Clone 9 cells. (*P<0.05; **P<0.005) 
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3.4.3 Dosage and time-course effects of F.F. on gene 
expression of GST 7-7 in H4IIE and Clone 9 cells. 
The expression of GST 7-7 subunit could be induced by the treatment 
of F.F. in both H4IIE and Clone 9. Results of the dosage-course study 
indicated that expression of GST 7-7 increased 1.61 and 1.82 fold when 
compared with the control in H4IIE and Clone 9 cells, respectively (figure 3.75， 
3.76). Inductive effects on GST 7-7 expression occurred continuously in Clone 
9 cells only whereas inductive effects of F.F. on H4IIE cells diminished when 
the concentration increased to 800 [jg/ml. 
Prolonged treatment with F.F. in both cell lines increased the 
expression of GST 7-7. GST 7-7 increased 1.70 fold in mRNA expression in 
H4IIE cells (figure 3.76) and 1.90 fold in Clone 9 cells (figure 3.77). The 
expression level increased after 8-hour incubation in both cell lines. The 
expression level reduced as the incubation time increased. 
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Figure 3.70 Northern blot analysis of the dosage-course effects of berberine 
on GST Ya expression in Clone 9 cells. (*P<0.05; **P<0.005) 
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Figure 3.76 Northern blot analysis of the dosage-course effects of F.F. on 
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Figure 3.77 Northern blot analysis of the time-course effects of F.F. on GST 
7-7 expression in H4IIE cells. (*P<0.05; **P<0.005) 
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4.1 Roles of A.H•，R.C., F.F. in the treatment and 
prevent ion of liver d isorders 
Abri Herba, Rhizoma Coptidis and Fructus Forsythia are commonly 
used traditional Chinese medicines for the treatment or prevention of liver 
disorders. These herbs are used for the remedy of hepatitis, jaundice, 
hepatoma. From the pharmacology of Chinese herbs, R.C. possesed broad-
spectrum bacteriostatic and antimicrobial effects and used for treatment of 
hepatitis. Berberine chloride also showed anti-inflammatory effects and growth 
inhibition of tumor cells (Chang et al., 1987). F.F. was a broad-spectrum 
antibiotic inhibiting many gram-positive and gram-negative bacteria. Anti-
inflammation property (Yukihiro et. al., 1997，2000) and action on acute viral 
hepatitis were reported. Data indicated it could rapidly lower serum 
transaminase in acute viral hepatitis. Reports also indicated that F.F. 
significantly alleviated hepatic degeneration and necroses induced by carbon 
tetrachloride and facilitatied the recovery of the hepatocellular glycogen and 
RNA to almost normal level (Chang et. al., 1987). With reference to the 
oriental materia medica，A.H. and abrine, its constituent, could reduce 
inflammation, inhibit hemolysis of red blood cells and relief chronic and acute 
hepatitis. 
4.2 Cytotoxic ef fects of A.H., R.C., F.F. in l iver cel ls. 
In this project, cytotoxic effects of A.H., R.C. and F.F. on liver cells had 
been studied. Neutral red assay was carried out to check the percentage of 
cell viability after treatment. Photospectrometry determination of cells viability 
was applied in this study. Cell membrane integrity was the focus of the study 
on cytotoxic effects of TCMs. Oxidative damage and osmotic effects of the 
aqueous extracts of TCMs were monitored. Experimental results indicated that 
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different responses occurred in normal and liver cancer cells. Results of the 
cyctotoxic study of A.H. indicated that aqueous extract of A.H. possessed 
significant growth-inhibitory effects in H4IIE cells. Effects of L-abrine seemed 
to be more effective in inhibiting cell growth of normal liver cells. These results 
indicated that A.H. might have other constituents that involved in the growth 
control of liver cancer cells. Rhizoma Coptidis possessed significant antitumor 
actions. The growth-response curves from the neutral red assay showed that 
both R.C. and its active constituent berberine could inhibit the cell growth of 
the H4IIE cells. R.C. was reported to contain 5 to 8 % of berberine. This active 
component showed various vital functions of R.C. from various 
pharmacological studies (Wen et. al., 1994.，Chang et, al, 1987). Effects of 
berberine on cell growth of liver cells showed similar results to that using the 
extracts of R.C. in cytotoxic study. This implicated that berberine might be the 
major active components in the antitumor functions of liver cancer. F.F. 
showed marked effects in inhibiting cell growth of liver cancer. More than 4 
fold difference of LC50 between normal and cancer cells was observed. It 
indicated that F.F. was the most effective in antitumor function among three 
TCMs. F.F. showed the least toxicity to liver cells. Study of actions of TCMs 
could help to reveal the actual pharmacological effects of TCMs and 
constituents could be isolated for the development of new drugs for the 
treatment of liver disorders. 
Cell growth inhibition effects of these TCMs and the hepatoprotective 
actions at the molecular basis were the aims of this project. The results of 
cytotoxicity study provided a guideline of a suitable range of dosage for the 
further study. The concentrations of 250, 20 and 100 |jg/ml were selected for 
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A.H., R.C. and F.F., respectively in order to minimize the effects of TCMs 
toxicity. 
4.3 Effects of herbal medicines on the t ranscr ipt ion of 
mRNA in liver cells. 
Pattern of gene expression induced by TCMs suggested the mode of 
actions of these herbs in the liver. Genes responsible for cell growth control 
and those related to the hepatoprotective functions were examined. cDNA 
array was used to characterize the effects of the three TCMs selected in this 
project. In this test, over 800 genes were studied from two different types of 
array mentioned in chapter 2. Genes induced by TCMs were analyzed and the 
role of these herbs in hepatoprotection at molecular level was studied. 
4.3.1 Effects of treatment of A.H. in liver at transcriptional 
level 
In the study of the effects of A.H. on the transcription of mRNA in liver 
cells, the mRNA of DT-diaphorase was increased by the treatment. This 
enzyme was effective in reducing oxidative damage by the obligate two-
electron transfer. DTD has been proposed to protect cells from the toxic and 
neoplastic effects of xenobiotic assaults (Winner et.al.,1996,; Yannai et. 
al.,1998) and tissue distribution study of DTD showed that high level of DTD 
gene expression has been observed in the liver (Belinsky et.al.，1993). 
Inhibition of DTD showed a marked increase in menadione-mediated 
mutagenicity (Williams et al., 1986). These data implied that induction of DTD 
expression by A.H. enhanced the ability of liver cells to reduce toxic and 
neoplastic effects of xenobiotics. P21 ；cip;waf1 was also induced by A.H.. This 
cell cycle regulator increased when compared with the control. This cyclin-
dependent kinase inhibitor inhibited the cell proliferation and played a role in 
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response to DNA damage of cells (Vogt et.al., 1998). The effective inhibition of 
cell growth in liver cells after hepatectomy by the induction of p21 was 
observed (Trautwein et., al., 1999). Role of p21 in cell growth control of 
hepatoma was studied. 
4.3.2 Effects of treatment of R.C. in the liver at transcriptional 
level 
The c-myc-responsive protein; rcl, was induced by the treatment of R.e. 
This growth-related protein was under the direct control of the c-myc genes 
and showed an elevated level in expression in a regenerating liver (Lewis et 
al., 1997; Schmidt, 1999). As the c-myc was the direct regulator of cell cycle 
maChinery, this downstream effector of c-myc also played a role in cell growth 
control. Increase in mRNA transcription level of rcl implied that the expression 
level of c-myc increased. The growth-related function of rcl in liver cells was 
demonstrated in the previous study (Lewis et aI., 1997). Results of this study 
suggested that R.e. might exert its inhibitory effects of the cell growth in H411E 
cells via the induction of rcl. From the list of the expressed genes, glutathione 
S-transferase Ya subunit was induced. This phase II detoxifiying enzyme 
plays a role in conjugation of xenobiotic. It was reported that a decrease in 
expression of mRNA and protein level of GST Ya in hepatitis B virus 
tranfected human liver cells (Jaitovitch-Groismant et al., 2000). Induction of 
GST Ya played a role in protection against xenobiotic in HBV infected patient. 
Expression of GST Ya also played a role in the treatment of jaundice by 
increasing the reduction of rat serum bilirubin. Dimeric form of GST Ya 
showed a high affinity in binding bilirubin for the excretion (Yin et al,.1993). 
Induction of GST Ya in both cell lines by R.e. suggested that protection 
against xenobiotics assaults in HBV infected patients could be enhanced. R.e. 
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and berberine also involved in the prevention of jaundice by reducing the 
serum bilirubin level due to the increased expression of GST Ya. 
4.3.3 Effects of treatment of F.F. in liver at transcriptional level 
In the study of F.F., cDNA expression array was used in this study. 
Results showed that only three genes were induced by the treatment of F.F. 
Glutathione S-transferase 7-7 was increased in expression when compared 
with the control. This putative preneoplastic marker gene was increased and 
played a role in binding bilrubin as well as diverse organic anions (Satoh et al., 
1991). This class of GST possessed unique enzymatic properties including 
broad substrate specificity and a high sensitivity towards active oxygen 
species (Tsuchida et., al., 1992). The expression of GST 7-7 increased the 
protection ability toward the damage of toxin and xenobiotics by conjugating 
wide range of its substrates. Over-expression of Pi class GST was reported in 
several tumors types (Wang et al., 1997) and the weak electrophile selective 
characteristics indicated that GST 7-7 played an important role in detoxifying 
the water-soluble carcinogens under the toxic condition (Kimihiko, 1998). It 
was inferred that induction of GST 7-7 by F.F. could increase the ability of liver 
to defend against the neoplastic effects of xenobiotics assaults. 
4.4 Compar ison of results of RT-PCR and Northern blot 
analysis. 
The expression level of genes induced by TCMs was confirmed by 
comparing the results of RT-PCR and Northern blot analysis. Time-course and 
dosage-course effects of TCMs were further studied in the analysis and results 
were compared in order to study the mode of actions of TCMs. 
4.4.1 Comparison of effects of time and dosage-course 
studies of DTD expression Induced by A.H, and L-abrine. 
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Fixed time dosage-course effects and the time-course effects were 
observed from RT-PCR and Northern blot analysis. Results indicated that A.H. 
could induce short-term DTD expression in both cell lines. Recent studies 
showed that expression of cFos was known to repress the ARE-mediated 
expression of DTD in liver cell lines (Ross et al., 2000). Thus, reduction in 
DTD expression after prolonged treatment suggested that A.H. might exert its 
inductive effects via ARE. It was negatively regulated by the control of cFos. 
In the treatment of L-abrine, DTD expression in H4IIE cells increased 
consecutively. The expression level was elevated and changed with the 
incubation time. Studies confirmed the expression level of DTD in H4IIE was 
greater than that in Clone 9 cells during the whole incubation period. This 
suggests that the repression effects of cFos in H4IIE were less effective when 
compared with the Clone 9 cells. As the purified L-abrine could induce the 
consecutive expression of DTD. The purity of L-abrine is an important factor 
inactivating the repression of cFos in DTD expression. 
4.4.2 Comparison of effects of time and dosage-course 
studies of p21;cip;waf1 expression induced by A.H. and 
L-abrine. 
The results of studies on p21 expression confirmed that level of p21 
was increased in H4IIE cells and showed an increasing trend of induction in 
both dosage and time-course studies after treatment of A.H. and L-abrine. 
Results from PGR and Northern blot analysis showed the increasing trend of 
p21 expression. The expression of p21 was recorded in Clone 9 cells also. 
However, the expression level increased in short-term fashion, and the 
expression level reduced as the incubation time increased. These results 
indicated that effects of A.H. and L-abrine could consecutively induce p21 
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expression in H4IIE cells. Increased in expression of p21 played roles in 
inhibiting cell growth of cancer cells, and it might contribute to the anticancer 
actions that were showed from the results of cytotoxic study. 
4.4.3 Comparison of effects of time and dosage-course 
studies of c-/nyc-responsive protein; rcl expression 
induced by R.C. and berberine. 
The expression level of rcl was determined by a dosage-course and 
time-course study with a fixed concentration of medicine. Increase in 
expression of rcl occurred when R.C. applied to H4IIE cells. The expression of 
rcl was not concentration-dependent and the expression increased in early 
stage of treatment. Prolonged exposure of H4IIE cells to R.C. diminished the 
expression level of rcl. In comparing the effects of R.C. in Clone 9 cells, the 
expression of rcl was less obvious, rcl was increased in response to the 
treatment of R.C., but no trend was obtained in dosage-course study. Time-
course effects of R.C. were effective in the early stage of incubation, but 
reduced as the incubation continued. In comparison of the effects of R.C. on 
rcl expression, induction of rcl expression with no obvious trend in dosage-
course study occurred in both cell lines. Results of time-course study showed 
that R.C. had short-term inductive effects on the expression of rcl. As the rcl 
played a role in regulating the cell growth via the control of c-myc (Lewis et al, 
1997), greater inductive effects of rcl by R.C. in H4IIE suggested that rcl might 
relate to the inhibition of cell growth of H4IIE. 
In H4IIE cells, the expression of rcl increased at a higher concentration 
of berberine (60 The expression of rcl was not concentration-dependent. 
Both results of PCR and Northern blot analysis showed the disproportion 
expression of rcl in H4IIE cells after treatment with berberine. However in 
-159-
Discussion 
Clone 9 cells, effects of berberine on rcl expression were opposite to those in 
H4IIE cells. The expression in Clone 9 decreased as the concentration 
increased. In comparing the time-course study of berberine in two cell lines, 
effective induction of rcl occurred at incubation time around 16 to 24 hours and 
both studies of confirmation showed similar results. Results suggested that 
berberine can regulate the cell growth of H4IIE cells via the induction of rcl 
and can play an important role as an anticancer agent. 
4.4.4 Comparison of effects of time and dosage-course 
studies of GST Ya expression induced by R.C. and 
berberine. 
From the results of PGR and Northern blot analysis, there was no 
obvious difference between the two studies. The dosage-course effects of R.C. 
on GST Ya expression was additive and concentration-dependent in both cell 
lines. This implied that R.C. and berberine were effective in preventing liver 
damage from xenobiotics assaults and excessive accumulation of bilirubin in 
serum. Enhanced of GST Ya expression by R.C. and berberine played an 
important role in these functions. Protective function of R.C. to liver could be 
achieved by increasing the detoxification. Prolonged exposure of both cell 
lines to R.C. and berberine diminished the expression of GST Ya. This 
suggests that some regulatory elements or factors were induced, and 
interacted with XRE or ARE to regulate the transcription of GST Ya. 
4.4.5 Comparison of effects of time and dosage-course 
studies of GST 7-7 expression induced by F.F.. 
Treatment of both H4IIE and Clone 9 with F.F. could induce GST 7-7 
expression. When comparing the results of the dosage effects of F.F., data 
indicated that consecutive expression of GST 7-7 occurred. Increased 
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expression of GST 7-7 indicated that the enhanced activity against lipid 
hydroperoxide and active oxygen species damage to liver cells. Enhanced 
host-defense ability also achieved due to the resistant properties of GST 7-7 
towards various inhibitors. 
4.5 Biochemical s igni f icance of genes induced by the 
hepatoprotect ive TCMs. 
As the induced genes were identified and confirmed by RT-PCR and 
Northern blot analysis, the possible roles of these genes in hepatoprotective 
functions were established. By understanding the roles and actions of genes 
in hepatoprotective functions, a formulation of TCMs could be developed in 
order to treat various liver diseases or provide the molecular basis for the 
development of new drugs from TCMs targeted to liver disorders. 
4.5.1 Roles of induced expression of detoxifying enzymes by 
TCMs in liver cells. 
In this study, two different phase II enzymes were induced by treatment 
with TCMs. The superfamily of glutathione S-transferase catalyzes the 
conjugation of glutathione (GSH) with a number of electrophilic compounds 
and acts as binding proteins. This group of enzymes plays important roles in 
the detoxification of drugs and carcinogens, lipid and DNA hydroperoxides. 
They involve in the hepatic uptake of bilirubin and intracellular transport of 
haem and steroid hormones (Litwack et., al., 1971). Induction of GST Ya 
increased the binding ability of bilirulin and help to prevent the formation of 
jaundice by transporting bilirubin from plasma the liver (Wolkoff et., al., 1979). 
The GST Ya was activated at the transcriptional level in response to treatment 
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of chemopreventive agents. These compounds were postulated to prevent the 
development or retard the progression of carcinogenesis (Fei et al.，1996). 
These results showed the correlation of the GST Ya and antitumor actions. 
DT-diaphorase was the other phase II enzyme induced by TCM in this 
study. This flavoprotein could catalyze the obligate two-electron reduction of 
quinone, quione imines and azo dyes. Several lines of evidence had indicated 
that DTD might have protective effect against carcinogenicity, mutagenicity 
and other toxicities caused by quinines and their metabolic precursors 
(Cresteil et al., 1991). Multiple upstream elements affected the transcription of 
DTD in response to the foreign compounds. The gene of DTD carried 
xenobiotic responsive element (XRE) was induced leading to transcription via 
the interaction with aryl hydrocarbon receptor. Aryl hydrocarbon receptor-
independent antioxidant response element (ARE) also conferred the 
inducibility in response to phenolic antioxidants, hydrogen peroxide, 
metabolites of planar aromatic compounds and other chemicals that undergo 
reduction to generate reactive oxygen speicies (Winner et., al., 1996). A high 
level of DTD gene expression had been observed in liver tumors as compared 
with the normal tissues of the same origin (Belinsky et., al., 1993). 
(i) Significance of GST Ya in liver cells induced by R. C. 
Effects of the treatment with R.C. and berberine increased the 
expression level of GST Ya. This detoxifying enzyme showed an obvious 
correlation to the prevention of liver disorder. Induction of GST Ya played a 
significant role in prevention and treatment of jaundice. The liver disorder is 
caused by excessive accumulation of bilirubin in plasma. Homologous dimeric 
form of GST Ya has remarkable affinity for this compound and transport it from 
plasma to cytosol (Yin et., al.,1993). This scavenger protein increased the net 
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uptake of bilirubin of liver by preventing back diffusion (Kaplowitz, 1980) 
according to the inversely proportion relationship between GST Ya 
concentration and efflux rate constant (Wolkoff et al.，1979). This homologous 
dimer could completely prevent the bilirubin inhibition of other classes of GSTs 
by reversible binding of GST Ya-Ya (Fukai et al., 1989). The enzyme activities 
of other GSTs were completely prevented from the inhibition of bilirubin. 
Conjugation of various electrophilic compounds and many planar 
aromatic substrates was the major enzymatic reaction by GST. The alpha 
class of GST catalyzed a broad range of hydrophobic substrates that involved 
in the formation of reactive species. This class of GST assumed a major role 
in the detoxification of carcinogens by catalyzing the alkylation of glutathione, 
rather than DNA, by carcinogens. Detoxification of these substances 
enhanced the protection from the assault by various toxic substrates to liver. 
Alfatoxin Bi was commonly found in the environment, and could induce 
different types of cancer. It showed resistance to various antioxidants against 
AFBi-induced neoplasia. Recent studies indicated that an excellent correlation 
was found between the hepatic GST Ya activity and the degree of inhibition of 
AFB1 -DNA adduct formation (Davidson et., al., 1990) 
Induction of GST Ya expression could be beneficial to the treatment of 
hepatitis. Decreased in mRNA level of GST Ya of the HBV transfected cells 
was observed and these cells became much more sensitive to a wide range of 
substrates of GST Ya. The HBx protein was involved in this action as this 
protein affected the cellular transcription machinery (Jaitovitch-Groisman et,. 
al.，2000). Hence, induction of GST Ya mRNA might help to encounter the 
down-regulation of GST Ya by R.C. and berberine. 
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Effect of R.C.and berberine on the GST mRNA was identified, but the 
mechanism of the gene transcription induced by R.C. and berberine was still 
unclear. The expression of this might be regulated by different mechanisms for 
the expression of GSY Ya. First, the Ah receptor interacts directly with one of 
several ligands and activates transcription after translocation to the nucleus 
and binding to the XRE. Second, Ah-receptor-ligand complex could up-
regulate CYP 1A1 permitting metabolism of substances to form metabolites 
that interact with ARE and activates transcription. At last, oxidative stress 
within the cell activated transcription through the ARE without the involvement 
of Ah receptor or P450 (figure 4.1). 
(ii) Significance of GST 7-7 induced by F.F. in liver disorders 
The GST 7-7 was the acidic Pi class GST and also conferred a broad range 
substrate specificity. GST 7-7 was induced in response to various chemicals 
that lead to carcinogenesis. Report indicated that GST 7-7 was elevated in 
transcript level by genotoxic carcinogens in a tumor of hepatocellular origin 
(Russell et., at., 1988). Induction of GST 7-7 by F.F. enhanced the protection 
ability of liver against these types of carcinogens. The alpha class GST has 
broad substrate specificity, but the target substrates are usually hydrophobic. 
Weak electrophilic characteristics of rat GST 7-7 made this type of isozyme 
catalyse weak electrophiles. The hydrophobic force played an essential role in 
defining substrate specificities due to the presence of H site and G site. 
Negative attraction of the solvent water molecules occurred. Weak 
electrophilic selective characteristic made GST 7-7 targets for weak 
eletrophiles, i.e. water-soluble carcinogens such as acrolein and hydroxy-
alkenals that might be expected to be particularly genotoxic. These properties 
of GST 7-7 lead to the high resistance to various hydrophobic inhibitors. The 
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results suggest that it is still active under toxic condition. GST 7-7 was also 
elevated in response to the production of endogenous carcinogens (Kimihiko 
Satoh, 1998). Long term dosing of genotoxic carcinogens lead to the high 
elevation in GST 7-7 transcript in tumor of hepatocellular origin (Russell et al., 
1988). 
Besides detoxification of carcinogens in liver, GST 7-7 was also 
elevated in response to exposure to pyrrole. This chemical species was 
present in the porphyin, ring structures porphobilinogen and its metabolite 
(bilirubin) through altered hepatic heme metabolism which is associated with 
hepatic diseases (Primiano et al., 1993). 
-165-
Discussion 
Aqueous extracts of R.C. 
A h r e c e p t c y / \ 恐 「 
yPF HMF1 — HMF^ APF  
• 
Inducible Basal and Liver Specific Basal and Inducible 
Expression Expression Expression Transcription 
• • 
Ah receptor 






Figure 4.1 Possible regulation of GST Ya gene induced by R.C. 
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W) Biological roles of DT-diaphorase in liver 
DTD was a putative phase II enzyme that catalyzed obligate two-
electron reduction. These characteristics prevented the formation of reactive 
intermediate from the single electron transfer from CYP and produced 
potential toxic semi-quinone radical intermediates. Limited autooxidation and 
formation of superoxide was achieved as the DTD converted quinone into the 
stable hydroqunine. The mRNA expression level of DTD in a developing tumor 
increased and thus showed the role of cellular defense during tumorgenesis 
(Belinsky et al., 1993). Induction of DTD implicated that increased ability of 
protection against hepatotoxic metabolite. Experimental evidences indicated 
that DTD protected cells from alkylation of macromolecules by acetaminophen 
metabolite (Powis et al., 1987). Recent report showed that DTD was capable 
of preventing reactive intermediate from alkylating or cross-linking of DNA 
(Gibson et al., 1992) and protected cells from menadione by hepatic oxidative 
damage (Ip et al., 2000) • The expression of DTD induced by A.H. enhanced 
the defense system of liver against various damage from reactive species or 
oxidative damage. 
4.5.2 Roles of Induction of growth-related c-myc responsive 
protein; rcl in R.C. treated liver cells. 
The growth-related c-myc responsive protein; rcl, was identified and 
characterized recently. c-Myc forms a heterodimer with Max protein and bind 
together to a specific DNA sequences CAC(A/G)TG or E-box and thus 
activated transcription. Since some c-myc target genes were regulators of cell 
cycle while other function in cell division pathway, c-myc became the interface 
of the cell division and cell growth (Schmidt, 1999). The down-stream effector 
of c-myc gene involved in this pathway directly correlated to the expression of 
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c-myc and affects the cell cycle. Rcl involved in the growth control as the 
expression of this gene was under direct control of c-myc that was the primary 
regulator of cell cycle machinery. Over-expression of c-myc increased the 
expression of rcl and this phenomenon also occurred in the growth system of 
regenerating liver (Lewis et al., 1997). Growth-related function of rcl was 
demonstrated in liver cancer cells when cells were treated with aqueous 
extracts of R.C. Correlation between the expression of rcl and cell growth was 
established and role of R.C. in cell proliferation on liver cells was obtained 
(Chan et., al., 2002). Antitumor function of R.C. in the liver was also 
demonstrated as the treatment of R.C. was effective in inhibiting the cell 
growth of hepatoma (Ho et al., 2002).. 
4.5.3 Roles of increased p21;cip;waf1 expression in A.H, 
treated liver cells. 
The cyclin-dependent kinase inhibitor p21 was the focal point that 
integrated many types of signals that showed impact on cell division and cell 
death. p21 protected cells from DNA damage or prostaglandin induced 
apoptosis and involved in other p53-dependent checkpoint control such as 
p53-clependent growth suppression (Deng et., al., 1995). The growth inhibitory 
effects of p21 had been found to suppress cellular transformation (Michieli et., 
al., 1996). Induction of p21 was observed in a wound and indicated that p21 
played a key role in supervising the cell proliferation in tissue repair (Zhu et al., 
2001) and the absence of p21 led to the loss in G1 arrest and defective in 
excision repair (McDonald et., al., 1996). Thus, an increased expression of 
p21 in the liver by A.H. reflected that enhanced protection of DNA damage 
and increased repair of tissue. The presence of oxidative stress enhanced the 
expression of p21 • Hence an increased DNA repair machinery was observed 
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(Kinoshita et., al., 2002). Thus, protection role of A.H. in the liver emerged at 
the enhanced repair machinery via the expression of p21. 
4.6 Conclusion 
In this study, three different putative TCMs with hepatoprotective 
function were investigated. Effects of TCMs on gene expression at 
transcription level revealed the gene expression pattern induced by various 
TCMs using cDNA array system. The genes are related to the function of 
detoxification of xenobiotics and other oxidative stress or toxic substrates. 
GST Ya, GST 7-7 and DTD were increased in gene expression by treatment 
with R.C., F.F. and A.H., respectively. An increased expression of these phase 
11 detoxifying enzymes implied enhancement of liver function against assaults 
from the environment. An increased transcription of these genes also played 
roles in the treatment of liver disorders as the evidence indicated that 
reduction of phase II enzymes occurred in hepatocytes when patient suffered 
from hepatitis or liver caner. Results suggest the correlation of the reduced 
phase II enzymes expression and increased sensitivity of xenobiotics from the 
environment. 
Other than detoxifying enzymes, genes related to the cell cycle control 
and cell growth were identified. c-Myc responsive protein; rcl, and p21 were 
induced significantly by R.C. and A.H. Growth related function of rcl in liver 
was the target of the study. Induction of rcl is involved in the cell cycle control 
and in regenerating the liver. The study provides an insight into the function of 
R.C. to liver protection. The increased p21 expression enforced the DNA 
repair and related to the cell cycle control. Thus it provided effective protection 
mechanism to liver. 
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Usage of TCMs for the treatment of liver disorders aroused interests. 
Limited side effects became the advantages over the synthetic drug for the 
liver diseases. By studying the action of TCMs at molecular level, the functions 
of TCMs could be better understood. Also, a new effective formulation for liver 
disorders can be developed. 
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